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INTRODUCTION: Investigating mechanisms of how intracellular bacterial pathogens 
such as Mycobacterium. avium (M. avium) evade the host immune response and replicate 
within macrophages is crucial to devising rational targets for host-directed therapies 
(HDT) against these associated diseases. This studied utilized the congenic mouse strain 
B6.Sst1S, which contains the super-susceptibility to tuberculosis (TB) allele. Among 
murine models of TB, this strain uniquely replicates human disease because mice develop 
granulomas with central caseous necrosis. Utilizing a susceptible model for M. avium 
infection, this study investigated the effect of mycobacterial pathogenesis on altering 
macrophage phenotypes and T cells distribution in areas of pulmonary granulomatous 
inflammation.  
METHODS:12 formalin fixed paraffin embedded (FFPE) lung sections from M. avium 
infected B6.Sst1S and B6 mice were examined microscopically (12 weeks post infection 
(wpi) n=5, 16 wpi=7). A targeted histology approach was initiated by using MRI 
coordinates to dictate the depths at which formalin fixed paraffin embedded (FFPE) lung 





discrete necrotizing granulomas, lungs were cut at sections representative of diffuse 
pathology at 2 mm into FFPE blocks. Using the Opal Method™ (Akoya Biosciences), 6-
plex immunohistochemical staining was performed with Arginase-1 (Arg1), inducible 
nitric oxide synthase (iNOS), CD68, CD3, M. tuberculosis antigen (cross-reacts with M. 
avium) and DAPI to segment nuclei. Slides were digitized by a Vectra Polaris™ 
fluorescent whole slide scanner. Autofluorescence was removed by InForm™, and image 
analysis (IA) was conducted using Halo™ IA software. Statistical analysis was 
conducted using GraphPad Prism™ 8.0.  
RESULTS: Sst1 mediated susceptibility was statistically evident at 16 wpi but not at 12 
wpi. B6.Sst1S mice showed a statistically significant (P <0.05) increase in M. avium+ 
cell expression in the non-inoculated lung lobes, but not the inoculated lung lobes. 
Pulmonary lesions within the inoculated and non-inoculated lung lobes contain different 
immune signatures. The predominately primary lesions of the inoculated lung lobes were 
associated with increased CD3+, M. avium+, and iNOS+ cell levels. When controlling 
for level of infection, there was lower levels of CD3+ cells within granulomatous lesions 
of B6.Sst1S mice, especially in the non-inoculated lung lobe. Controlling for level of 
infection also revealed elevated iNOS+ M. avium- cell expression in B6 mice. We 
observed elevated Arg1+ cell expression near iNOS+ M. avium+ cells, and, qualitatively, 
around larger lesions. T cell proximity analysis was contradictory and offers lessons for 
future the development of future IA modules.  
CONCLUSIONS: Sst1 mediated susceptibility was evident at 16 wpi and predominately 





associated with fewer supportive cells (T cells and iNOS+ M. avium-  cells) within 
granulomatous lesions. Future studies are necessary to evaluate to what degree 
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The specter of increased global transmission of infectious diseases (ID) represents 
a crucial international health challenge accelerated by increasingly globalized economies, 
widespread human travel, changing climates, and the development of antimicrobial 
resistance to common antibiotics (Holmes et al., 2017; Patz, Frumkin, Holloway, Vimont, 
& Haines, 2014). A prime example of both the persistent and evolving nature of ID 
epidemiology is the tuberculosis complex (MTC) and nontuberculosis complex (NTM) 
mycobacterium species. Among the MTC organisms, Mycobacterium tuberculosis (M.tb) 
infection causes Tuberculosis disease (TB), which the World Health Organization 
estimates causes 10.4 million new cases and 1.8 million deaths each year (Holmes et al., 
2017). While TB burden has decreased worldwide over the past several decades, 
particularly in high-income countries, prevalence and incidence has remained high in 
high-burden countries such as in South-East Asia and Sub-Saharan Africa (Holmes et al., 
2017). Medical factors involved with the persistently high TB burden include low case 
detection, emergence of drug-resistant TB, and complications associated with HIV/AIDS 
coinfection (Holmes et al., 2017).  
While TB has been a significant driver of ID mortality for centuries, NTM 
causing pulmonary infections represent an emerging ID with increasing incidence in 
high-income countries with low TB prevalence. In the United States, the prevalence of 
NTM is ten times that of TB (Verma et al., 2019). Describing the global epidemiological 





universally reportable illnesses, and there is great variety in clinical presentation, testing 
criteria, and diagnostic resources throughought the world. In Australia, where NTM 
pulmonary infections are reportable, incidence of clinically significant diseases rose from 
2.2 (1999) to 3.2 (2005) per 100,000 population (Thomson, Centre, & Queensland 
Mycobacterial Reference, 2010).  Beyond Australia, numerous large population-based 
studies have shown increasing incidence of NTM pulmonary disease in North America 
and Europe (Prevots & Marras, 2015). Data from North America and Australia estimates 
the annual rate of disease at 3.2-9.8/100,000 persons, and 2 per 100,000 in Europe. In 
Central and South America, East Asia, and the Middle East, limited population studies 
exist, but studies from single institutions have suggested increasing prevalence of NTM 
pulmonary infections in East Asia. In Africa, research has focused on the suspicion that a 
portion of patients with suspected drug sensitive and resistant TB may in fact have NTM 
infection instead (Prevots & Marras, 2015). Reasons for the increasing prevalence of 
NMT pulmonary infections is not completely understood and likely multifactorial; 
suggested reasons include ageing population with greater susceptibility, and persistence 
in water treatment systems that evolutionarily select for NTMs (Busatto, Vianna, da 
Silva, Ramis, & da Silva, 2019) (Whiley, Keegan, Giglio, & Bentham, 2012). 
Given the persistent and dynamic global epidemiological burden of mycobacterial 
infections, research aimed at understanding mechanisms of bacterial resistance to the host 
immune response are necessary to identify new biological targets to afford rational 
vaccine and medical countermeasure development. While the late 19th and 20th century 





development of novel classes of antibiotics, leveraging 21st century technologies with a 
systems biology and data informatics paradigm is pivotal to further advance our 
knowledge and mitigate the global public health burden affiliated with IDs. The 
development of host-directed therapies (HDT) for chronic IDs like mycobacterial 
infections could help fill limitations associated with antibiotic therapy, such as prolonged 
treatment course, and the development of multi-drug resistant TB. Because HDTs aims to 
enhance immunity to pathogens or mediate immune pathways to prevent excessive 
immunopathology, these approaches could prove efficacious especially in the context of 
antibiotic resistance (Zumla et al., 2016).  
Induced by stimulation from infectious and non-infectious agents, granuloma 
formation is a key feature of a number of pulmonary diseases, including those caused by 
MTC and NTM mycobacterial species (Ramakrishnan, 2012). While granulomas are 
increasingly understood to represent a dynamic and heterogeneous immune response, 
standard features include organized aggregates of macrophages with varied 
characteristics including caseous necrosis. Additionally, neutrophils, lymphocytes, 
dendritic cells, natural killer cells, and fibroblasts may also be found in a pulmonary 
granuloma (Ramakrishnan, 2012). While granuloma formation may initially serve as a 
protective host response, in susceptible individuals, mycobacteria evade these protective 
mechanisms and granulomas form central caseous necrotic centers that promote bacterial 






Given the complexity of mechanisms by which mycobacterium pathogens perturb 
immune responses, utilizing animal models that faithfully recapitulate key features of 
human diseases is important to answer questions about pathogenesis and immunity. 
Previous work has shown that susceptible mouse strains inoculated with M. tb are capable 
of developing the defining histopathological feature of human TB: pulmonary 
granulomas with central areas of caseous necrosis (Ramakrishnan, 2012). By utilizing a 
susceptible mouse strain inoculated with M. avium, we are enabled to study features of 
mycobacterial granuloma pathogenesis and host immunity. The primary benefit of 
experimentation with M. avium is that experimentation can occur at a lower level of bio-
safety level laboratory compared to M. tb (BSL2 vs BSL3). While there are critical 
limitations to extrapolating M. avium results to M. tb, as will be discussed, this infection 
in a susceptible mouse strain allows us to develop analytic tools to decipher 
morphomolecular signatures of granulomatous inflammation during mycobacteriosis 
pathogenesis.  
 
MYCOBACTERIAL PATHOLOGY IN HUMANS  
 
 While both M.tb and M. avium infections are capable of causing pulmonary disease, 
there are unique clinical distinctions that differentiate these mycobacteria, as summarized 
in Table 1. 
 Given the long history of persistent global TB disease burden, the clinical 





infection. Patients with active TB most commonly present clinically with chronic cough, 
fever, weight loss, wasting, and hemoptysis. Diagnosis is made through cytologic 
analysis and confirmation of acid-fast bacilli and culture of clinical specimens (i.e. 
sputum, bronchoalveolar lavage) or pulmonary biopsies (Cadena, Fortune, & Flynn, 
2017). Mtb is readily transmitted to naïve cohorts by TB patients whom cough and 
aerosolize respiratory droplets containing infectious M.tb. Once inhaled, macrophages 
and dendritic cells phagocytize M.tb and develop cell mediated immunity (CMI) that is 
microscopically characterized by macrophage and T cell infiltration at the site of 
infection (Mathema, Kurepina, Bifani, & Kreiswirth, 2006).  
At this juncture, approximately 90% of infected individuals will mount an 
effective immune response and not develop clinical symptoms. In these resistant hosts, 
bacterial dissemination is prevented with involvement restricted to the primary 
pulmonary lesions at the site of infection, and potentially the draining lymph node 
(Mathema et al., 2006). Granuloma formation is classically defined as a central locus of 
macrophages with ingested mycobacteria surrounded by non-infected macrophages, 
peripheral T cells, and fibroblasts. Central caseating necrosis is a hallmark of TB 
granulomas in human patients. The granuloma formation is initially a mechanism of 
protective immunity that contains pathogens at the primary sites of infection (Cadena et 
al., 2017). In the approximately 10% of susceptible individuals, however, a divergent 
pathogenesis occurs that enables progressive mycobacterial replication and 
dissemination, increased granulomatous lesions in the lung, and potential hematogenous 





tissues. Eventually, the pulmonary lesions evolve in cavities that promote Mtb spread via 
aerosols. (Mathema et al., 2006). While this binary paradigm between active and latent 
TB infection (LTBI) is well established clinically, increasingly researchers have aimed to 
characterize the heterogeneity of TB pathogenesis and the spectrum of susceptibility.  
Among NTM pulmonary diseases, the most common etiological agent is 
Mycobacterium avium complex (MAC) species, which refer to biologically similar 
Mycobacterium avium (M. avium) or Mycobacterium intracellulare. Although some 
features, such as evasion of macrophage cytotoxic killing and pulmonary granuloma 
formation, are shared between M. avium and M. tb infection, a primary defining 
divergence is their environmental niche. Whereas M.tb is an obligate human parasite with 
extreme selective pressure to evade host immunity (Hunter, 2011), M. avium exists both 
within and outside mammalian hosts, including in soil and aquatic environments (Diel, 
Lipman, & Hoefsloot, 2018). Unlike TB, transmission is not normally thought to occur 
person to person (although this point is controversial in the setting of Cystic fibrosis 
(Skolnik, Kirkpatrick, & Quon, 2016), but rather through environmental exposure. MAC 
infections are also highly associated with concomitant underlying pulmonary disease 
such as Cystic Fibrosis and Chronic Obstructive Pulmonary Disorder (Busatto et al., 
2019; Skolnik et al., 2016).  
In addition, the concept of latent MAC infection is controversial, whereas LTBI is 
established with M.tb infection (Griffith et al., 2007). Supporting the notion of “latent 
MAC” infection, clinical observations have noted that Tumor Necrosis Factor (TNF) 





LTBI (Cha et al., 2015) However, there is little experimental evidence for latent 
infections with MAC infection. While incidence and prevalence of both M.tb and MAC 
infections are increased in immunosuppressed patients such as those with Acquired 
Immune Deficiency Syndrome (AIDS), M. avium infection more often occurs during 
late-stage AIDS and is less frequently identified as the primary pathogen compared to TB 
(Appelberg, 2006). Despite differences in natural history, M.tb and MAC share several 
critical features of pathogenesis and host immunity.  
Table 1: Comparison of unique clinical findings in pulmonary TB vs. pulmonary M. 
avium infection.   
Mycobacterial disease  TB  M. avium pulmonary 
infection 
Transmission Source Human to Human. Environmental, soil and 
water sources  (Busatto et 
al., 2019).  
Unique Clinical Findings  More likely to exhibit 
Constitutional symptoms; 
more likely to be using 
immunosuppressive 
medications (Kendall et al., 
2011).  
More likely to have chronic 
obstructive pulmonary 
disease; associated with 
other diseases affecting 
pulmonary architecture such 
as cystic fibrosis and lung 
cancer or underlying 
immunosuppression 
(HIV/AIDS) (Busatto et al., 
2019),  
Unique Chest Radiograph 
Findings 
More likely to have 
pulmonary cavitation 
(Kendall et al., 2011); 
Presence of multiple small 
nodules under 1 cm with 
associated bronchiectasis 
(Schluger, 2007)  
High degree of 
heterogeneity, may have 
cavitary lesions (like TB) or 
nodular bronchiectasis   






MYCOBACTERIAL DISEASE PATHOGENESIS – INSIGHTS FROM ANIMAL 
MODELS 
 
 A comparison of mycobacterial pathogenesis and host immunity is summarized in Table 
2. Table 2 is based off of findings from animal models of M. avium and M.tb 
experiments. 
Table 2: Comparison of molecular signatures of pathogenesis and host immunity 




Initiation of Infection Inhalation of aerosols 
containing mycobacterium 
(Kramnik & Beamer, 2016).  
Inhalation of aerosols 
containing mycobacterium 
or absorption through the 
gastrointestinal tract 
(Appelberg, 2006).  
Initial Host cell infected Phagocytic/macrophages in 
the lung (Flynn & Chan, 
2001). 
Phagocytic/ macrophages in 
the lung (Appelberg, 2006) 
Macrophage effector 
mechanism 
Susceptible to NO (Flynn & 
Chan, 2001). 
Relatively resistant to NO 
(Appelberg, 2006); NO may 
contribute to 
immunopathology.  
Role of neutrophils Neutrophils infiltrate 
granulomatous lesions early 
in infection; may contribute 
to protection early in 
infection, and 
immunopathology late in 
infection (Kramnik & 
Beamer, 2016)  
Neutrophils infiltrate 
granulomatous lesions early 
in infection, protective role 






Nagai, Suzuki, & 
Nishimura, 2018).   
Major cytokines 
implicated in infection 
control 
TNFa, IFNg, IL-12; 
controversial roles of IL-4, 
IL-10, TGF-b (Flynn & 
Chan, 2001). IL-17 
TNFa, IFNg, IL-1, IL-6, IL-
12 (Appelberg, 2006).  
Major adaptive immune 
responses implicated in 
CD4 T cells via IFNg; CD8 
cells less well 
CD4 T cells via IFNg; 





infection control characterized; controversial 
role of Th2 (Flynn & Chan, 
2001). 
controversial role of Th2 
mediated immunity, 
perhaps minor (Appelberg, 
2006).  
Major factors implicated 
in granuloma formation 
and necrosis 
Macrophage necrosis; 
Super-induction of IFN1 (Ji 
et al., 2019).  
Complement C5 
component; 
Over production of 
protective cytokines; 
(Kramnik & Beamer, 2016). 
 
While M.tb and M. avium, have unique elements in their clinical and molecular 
signatures, they also share pathogenic features. In pulmonary manifestations, both species 
of mycobacterium are phagocytosed by macrophages in the lung and may be associated 
with granulomatous inflammation and tissue necrosis. Using the common C57BL/6 
mouse strain, research on mediators of necrosis in M. avium infection has focused on 
activation of complement C5 and the Interferon gamma (IFNg) CMI axis. (Appelberg, 
2006).  In an experiment with a virulent strain of M. avium in C57BL/6 mice, mice 
developed organized granulomas in pulmonary tissue. Deletion experiments further 
established that CD4+ T cells promoted granuloma formation and enhanced production 
of TNFa and IFNg (Hansch et al., 1996). These findings with M. avium infection confirm 
the ability to investigate pulmonary granulomatous pathogenesis in models other than 
with M. tb.  
 Alveolar macrophages (AM) are increasingly well established as representing the 
initial environmental niche for M.tb replication once it reaches distal airways (Kramnik & 
Beamer, 2016). In C3HeB/Fej mice, micro-necrotic pulmonary lesions are present 2-3 





predominately formed by bone marrow derived monocytes (BMDM) and are associated 
with a Th1 T cell response (Kramnik & Beamer, 2016). This Th1 response is essential for 
infection control in C3HeB/Fej mice, as T cell deficient mice exhibit profound 
pulmonary disease with disseminated bacterial spread to distal organs (Kramnik & 
Beamer, 2016). The central macrophage necrosis evident during active infection is 
thought to represent dysregulated macrophage cell death pathways. Instead of responding 
to IFNg and IL-12 and executing effective microbicidal actions, in susceptible mouse 
models’ macrophages undergo necrosis and M.tb proliferate. Local factors in the 
granuloma microenvironment implicated in promoting this necrotic phenotype include 
hydrolytic enzymes from macrophages and neutrophils and Type 1 Interferon (IFN1) 
induction (Kramnik & Beamer, 2016). Systemic factors promoting the necrotic 
phenotype are less well defined (Kramnik & Beamer, 2016). 
MYCOBACTERIAL DISEASE HOST RESPONSE – INSIGHTS FROM ANIMAL 
MODELS 
Macrophage immunometabolism 
Characterizing how mycobacterial pathogens perturb macrophage immunometabolic 
pathways is essential to elucidate mechanisms that mediate their evasion of the host 
immune response. Two cytokine inducible macrophage enzymes that mediate an immune 
response include inducible nitric oxide synthase (iNOS) and Arginase-1 (Arg1). In vitro 
data has clearly established a binary paradigm of macrophage phenotypes, shown in 






Figure 1: Macrophage immunometabolism (Figure copied from: Huang, Nazarova, 
Tan, Liu, & Russell, 2018). 
 
iNOS expression is reserved predominantly for “M1” or “classically activated” 
macrophages. This M1 phenotype is typically associated with a Th1 T cell response 
(IL12, TNF, and IFNg cytokine production by CD4+ T lymphocytes). iNOS metabolizes 
arginine to nitric oxide (NO) and citrulline, which lead to the generation of strong 
antimicrobial reactive oxygen species within macrophages. Cytokines believed to inhibit 
iNOS expression include IL-10 and TGFb, while IL-4 inhibits NO production by 
inducing Arginase-1 (Arg1) expression in macrophages (reviewed in Rath et al). On the 
other hand, Arg1 expression is reserved for “M2” or “Alternatively activated” 
macrophages. This phenotype is associated with a Th2 T cell response (IL-4, IL-13 
cytokines). Arg1 competes with iNOS for arginine and catalyzes its hydrolysis to 
ornithine and urea (Rath et al. review). With important consequences for CMI, ornithine 





tissue repair processes (Rath et al. review) (Wynn, 2003). These M1 and M2 macrophage 
phenotypes are useful conceptualizations when investigating macrophage function, 
however is likely overly simplified in an in vivo context (Russell, Huang, & VanderVen, 
2019). 
While this binary paradigm is well recapitulated with in vitro models and does 
yield a useful framework to investigate the relationship between macrophage metabolism 
and T cell mediated immunity, the in vivo reality is more complex and macrophage 
metabolism is more fluid (Russell, Huang, & VanderVen, 2019). Additionally, relevant to 
mycobacterial pulmonary infections, AM may exhibit a unique immunometabolism 
profile. Unlike interstitial macrophages (IM) that infiltrate pulmonary tissue during an 
inflammatory process, AM populations are embryonic of origin (Huang et al., 2018), and 
committed to mitochondrial oxidative phosphorylation (Russell et al., 2019). AM’s 
increased oxidative phosphorylation expression, a feature associated with the M2 
phenotype, may increase their susceptibility to mycobacterial infection. Conversely, IM 
are BMDM, more glycolytically active, and therefore consistent with the M1 phenotype 
(Russell et al., 2019) (Huang et al., 2018). While the immunometabolic profile is a clear 
factor that mediates susceptibility to mycobacteria, animal model research has produced 
diverse and sometimes conflicting information about the role of M1 and M2 phenotypes 





M1 and M2 Phenotypes in Mycobacterial Research 
While AM’s express iNOS in patients with TB (Nicholson et al., 1996), the 
expression ratio of iNOS and Arg1 likely alters depending on the inflammatory state of 
the granulomatous lesion (Flynn, Gideon, Mattila, & Lin, 2015). Recent non-human 
primate (NHP) models of TB have yielded new insights. Using Cynomolgus Macaques, 
immunohistochemical (IHC) experiments yielded co-expression of iNOS and Arg1 
throughought necrotic lesions, with the peripheral lymphocytic cuff containing a high 
ratio of Arg1:iNOS macrophages. While they hypothesized that the enhanced Arg1 and 
iNOS expression would deplete arginine in the granuloma microenvironment and thereby 
inhibit T cell responses (Mattila et al., 2013), other studies with NHP have postulated a 
protective role of Arg1 (Flynn et al., 2015).  Limited and conflicting studies have also 
been generated using mouse models. 
The contributions of iNOS and Arg1 in controlling mycobacterial infection and 
influencing the generation of granulomas in murine models are under investigation. In M. 
tb, NO is known to mediate the bactericidal activity of macrophages. In a model with 
dermal M.tb infection and iNOS knockout, Arg1 was found to be protective in reducing 
bacterial burden, yet modulated T cells by decreasing their proliferation to granulomas 
(Duque-Correa et al., 2014). Conversely, as described in numerous in vivo and in vitro 
studies with M. avium infection, iNOS is not necessary to mediate the cytotoxic function 
of macrophages to kill ingested M. avium (Appleburg 2006). In fact, murine models have 





with M. avium, iNOS knockout mice exhibited increased resistance, elevated serum 
IFNg, and increased granuloma formation in the liver. These researchers also showed that 
IFNg promoted infection control from an NO-independent mechanism (Gomes, Florido, 
Pais, & Appelberg, 1999). Other studies with BALB/c mice have shown that enzymatic 
inhibition of iNOS increased the size and number of granulomas and was associated with 
an increased number of lymphocytes and macrophages within granulomatous lesions in 
the liver (Ehlers et al., 1999) More recent research has focused on potential mechanisms 
by which iNOS expression may regulate T cells and down regulate Th1 CMI because NO 
influences IL12 (Xue, Yan, Zhang, & Xiong, 2018). With respect to Arg1 expression, 
previous research has shown that iNOS deficient mice infected with M. avium developed 
more severe fibrosis around liver granulomas than control. Notably, however, this, study 
did quantify the population of Arg1+ cells around the granuloma (Lousada, Florido, & 
Appelberg, 2006). Indeed, defining the relationship between iNOS, Arg1, and CMI is still 
an area of significant research in mycobacterial infections.  
The most important difference between M. tb and M. avium in regard to host 
immunity may be that NO is not necessary for infection control in the latter. The reason 
for this divergence may be due to the fact that M. avium infection in mice is partly under 
the control of the gene Nramp1, or more recently called SCL11a1 (Appleburg 2006). The 
protein encoded by this gene controls cation levels inside a macrophage’s phagosome and 
cytosol (Appleburg 2006). Given the different environmental exposures that M. avium 





species is that M. tb evolved mechanisms to evade nutrient deprivation influenced by 
Nramp1 (Appleburg 2006). It has also been hypothesized that the aquatic environments 
in which M. avium is found my also contain nitrates, which would establish an 
evolutionary force for resistance to NO (Appleburg 2006).  Regardless of the etiology of 
this difference, this divergence should be considered when extrapolating results of an M. 
avium infection model to an M. tb model.  
Adaptive Immunity to Mycobacterial Infections 
Adaptive immunity to mycobacterial infections is predominantly driven by CMI. The 
Th1 T cell response pattern of Tumor Necrosis Factor alpha (TNFa) induction and 
production of IFNg to facilitate the microbicidal effects of macrophages is well 
characterized in murine models of M.tb and M. avium (Kramnik & Beamer 2016) 
(Appelburg 2006). Studies have pointed to a role for IL-4/IL-13 induced Th2 T cell 
responses in disease progression. For example, a study with C57BL/6 DBA/2 F1 hybrid 
mice with intratracheal M.tb inoculation found elevated IL-4 levels in granulomas of 
mice with progressive disease (Arriaga, Orozco, Aguilar, Rook, & Hernandez Pando, 
2002). While less research exists than with M.tb infection, studies with murine models of 
M. avium infection have shown little induction of IL-4 and therefore Th2 immune 







Mouse Models of Mycobacterial Infection  
Regardless of the mouse strain, there are important limitations when utilizing a mouse 
model to study mycobacterial infections. Mice are not a natural host for M.tb or M. 
avium, and the infection is not transmissible between mice. Despite these limitations, 
mouse models of mycobacterial infections have been widely and effectively used to 
elucidate key features of pathogenesis and host immunity. For example, deletion 
experiments with severe combined immunodeficient, T cell Receptor, IFNg, and iNOS 
knockout mice, established the essential of the Th1 response to control M.tb infection 
(Kramnik 2008). Many other experiments have well-established the role of Th1 mediated 
immunity in mycobacterial control of both M.tb and M. avium through genetic dissection 
analysis of susceptable hosts (Reviewed in (Casanova & Abel, 2002).  
Historically, among many mouse models of mycobacterial infections, the primary 
limitation was the lack of development of pulmonary granulomas with centrally necrotic 
centers in the context of an immunocompetent host (Pichugin, Yan, Sloutsky, Kobzik, & 
Kramnik, 2009). Given that the progressive development of necrotic pulmonary lesions is 
crucial for disease progression and transmission to other hosts, the utility of studying host 
immunity with mouse models lacking this feature is controversial. The most commonly 
used murine strain for mycobacterial research, C57BL/6 (B6), is relatively resistant to 
TB, with pulmonary lesions generally lacking necrosis (Kramnik & Beamer, 2016). 





feature of pathogenesis, extensive genetic research and crossbreeding was performed to 
dissect the multigenetic nature of host resistance to mycobacteria in mouse models 
(Kramnik 2008). Despite lacking a known immunodeficiency, the C3HeB/FeJ (HeB) 
inbred strain exhibited extreme susceptibility to M.tb and development of large 
granulomatous lesions with central caseating necrosis. When challenged with the same 
strain of M.tb via intravenous infusion, C3Heb/Fej mice survived only between 25-28 
days whereas B6 mice survived for 10-40 weeks (Kramnik 2008). Mapping TB 
susceptibility loci in a hybrid F2 generation between the C3Heb/Fej and B6 mice, it was 
found that homozygosity for the C3H-derived segment of chromosome 1 was associated 
with the development of necrotic TB lesions in the lungs. This genetic locus was called 
super-susceptibility to tuberculosis (sst1). Congenic mouse strains were then generated 
using the Sst1 allele on different genetic backgrounds to establish susceptible and 
resistant strains. The Sst1-resistant (Sst1-r) allele encompasses the sst1 region on 
chromosome 1 from the B6 strain, and the Sst1-Susceptible (Sst1-s) allele encompasses 
the sst1 region on chromosome 1 from the Heb strain (Kramnik and Beamer, 2016).  
Table 3 summarizes difference between the commonly used B6 strain and B6.Sst1S, 
which has the Sst1-S allele on a B6 genetic background.  
Table 3: Comparison of B6 and B6.Sst1-susceptible strains following low-dose M.tb 
aerosol challenge (Kramnik and Beamer, 2016).  
Strain C3H.B6 (B6) B6.Sst1-Susceptible 
2 wpi (following challenge 
with aerosol low-dose 
M.tb (15-20 CFU) ) 
Initial increase in bacterial 
replication, then decreased 
burden following initiation 
of adaptive immunity.  





6 wpi Compact lesions with no 
necrosis, abundant 
lymphocytes and 
mononuclear phagocytes.  
Same as B6 but with 
increased bacterial 
replication compared to B6, 
no necrosis present.  
9-12 wpi Interstitial fibrosis may be 
present, but no organized 
granulomas with central 
necrosis.  
Generation of large, several 
millimeter sized organized 
granulomas; thick fibrous 
capsule with sparse T cells 
infiltrating granuloma. 
iNOS positive cells within 
granuloma core.  
 
Sst1 Mediated Susceptibility To Mycobacterial Infections 
 
The sst1 gene is also implicated in susceptibility to other intracellular infections, however 
this model has not yet been applied to M. avium infection. Further research has 
established that the phenotype is driven by non-lymphoid BMDM and is involved with 
mediating metabolic signals that drive macrophage apoptosis/necrosis pathways that 
contribute to tissue damage (Kramnik 2008). Therefore rather than influence T cell 
trafficking or Th1 cytokine production, sst1 is thought to control the innate immune 
response of BMDM in an Type 1 Interferon (IFN1) dependent and iNOS independent 
mechanism (Ji et al., 2019) (Yan et al., 2007). The protein encoded by this gene, Ipr1 
(also called SP110) is a nuclear protein induced by IFN1. Although the precise 
mechanism is not fully characterized, recent studies implicate the Sst1 phenotype to a 
TNF-induced dysregulated stress response in macrophages and IFN1 super-induction 





strains of M.tb infection has shown that IFN driven susceptibility was mediated by an IL-
1 receptor, IL-1Ra (Ji et al., 2019).  
 Evaluating the immunological pathways associated with this phenotype may offer 
important insights into vaccine or HDT targets. For example, using this model, the live 
attenuated vaccine Mycobacterium bovis bacillus Calmette-Guérin (BCG) failed to 
provide long-term protection against M.tb infection in the lungs of infected mice  (Yan et 
al., 2007). This finding implies that the barrier to successful vaccine development and T 
cell mediated HDT may be that these strategies do not address the underlying 
dysregulated stress response in macrophages. Indeed, the sst1-susceptible mouse model is 
a unique model that may uncover fundamental aspects of macrophage necrosis at the 
cellular level important to the development of novel anti-mycobacterial therapies.  
Systems biology and temporospatial analysis of host-pathogen signatures  
For the past two decades, there has been increasing focus on the heterogeneity of 
pathogenic mechanisms and immune responses to infection. For example, in C56BL/6 
mice, differential gene expression was shown to occur in response to various metabolic 
changes at different stages of TB granuloma formation, oxygen levels, and nutrient 
content (Timm et al., 2003). Another study using in situ hybridization of different M.tb 
DNA and mRNA nucleic acid targets and IHC to identify CD68+ macrophages on  
patient lungs with TB highlighted that heterogeneity among granulomas, even within the 
same patient, may correspond to the granuloma microenvironment. (Fenhalls et al., 





around areas of caseous necrosis. In addition, CD68+ macrophages with mycobacterial 
mRNA were also identified (Fenhalls et al., 2002).  
 More recent studies have utilized new imaging modalities such as positron 
emission tomography combined with computed tomography to differentiate and risk 
stratify four types of pulmonary lesions in patients with LTBI, antiretroviral negative, 
human immunodeficiency virus-1 (HIV) infected individuals in South Africa. In doing 
so, they challenged the binary clinical paradigm existing between active TB and LTBI 
(Esmail et al., 2016). Recent studies have also pushed to a systems biology approach by 
predicting risk of TB reactivation through whole blood transcriptional signatures 
(reviewed in Cadena et al., 2017). The advent of new biological research approaches has 
shifted emphasis to evaluating pulmonary lesions along a spectrum with emphasis on 
how unique microenvironments influence pathogenesis and the host response (Barry et 
al., 2009). By employing tools that provide quantitative outputs and afford analysis of 
multiple biomarkers, mycobacterial infections can be classified with greater precision 
with the goal of patient stratification according to the disease mechanisms and identifying 




The two most common methods to stain for mycobacteria in fluid and tissue 
specimens are the Ziehl-Neelsen acid fast method or the Auramine-Rhodamine method. 





mycobacterial pulmonary lesions have historically been evaluated by qualitative analysis. 
For example, in the 19th and early 20th centuries caseating granulomas were termed 
productive lesions, and tuberculous pneumonia was termed exudative lesions (Hunter, 
2011).  Given the changing nomenclature and evolving characterization of TB lesions as 
technology progressed, it has been difficult to for researchers to produce consistent and 
comparable measures of pathologic phenotypes. This is exacerbated in the clinical setting 
given the fact that since the era of antibiotics, few pathologists have examined tissues 
from untreated pulmonary TB in human patients (Hunter, 2011).  
In addition to morphological analysis of tissue pathology, IHC offered researchers 
the ability to identify specific cell types and compare serial sections of tissue. Recent 
work has shown a differential staining pattern of M. tb secreted and somatic antigens in 
pulmonary and lymphatic tissue. These researchers’ also suggest that the lack of secreted 
antigens in well-formed granulomas indicate control of infection (Mustafa, Leversen, 
Sviland, & Wiker, 2014).  By combining the ability to stain for mycobacterium with IHC 
antigens and to identify cell types involved with granulomatous inflammation, novel 
insights can be made into disease pathogenesis.   
Building off the use of IHC to study mycobacterial infection, the advent of 
multiplexed IHC (mIHC) paired with image analysis (IA) offers researchers and 
clinicians a powerful tools to provide quantitative morphomolecular signatures of disease 
progression not feasible with traditional approaches (Stack, Wang, Roman, & Hoyt, 
2014). The ability to phenotype individual cells through molecular signatures in a single 





Multiplexed staining of tissues may be achieved through brightfield or fluorescent 
microscopy. Brightfield multiplexing relies on chromogenic deposition. However, it is 
usually limited to targeting three biomarkers in unique cells or cellular compartments 
because of chromogenic spectral overlap (Stack et al., 2014). Fluorescent multiplexing, 
however, offers increased capacity in terms of number of molecular markers targeted and 
enhances the ease of investigating colocalized markers given images are created in layers 
through use of specific filters sets and subsequently overlaid computationally (Stack et 
al., 2014). By utilizing fluorophores with distinctive excitation and emission spectra 
coupled with compatible fluorescent filters, fluorescent multiplexing can readily decipher 
spatial distribution of multiple molecular markers simultaneously (Stack et al., 2014).  
Conventional indirect mIHC is limited by the requirement that each primary 
antibody be derived from a unique host species or isotype and react with a specific 
secondary antibody. This requirement significantly complicates acquiring the necessary 
reagents and potentially limits which molecular markers may be targeted. This limitation 
is abrogated with the use of Tyramide Signal Amplification (TSA), which amplifies 
fluorophore signal before binding to a specific primary-secondary antibody complex 
(Stack et al., 2014).  This primary-secondary antibody complex can then be removed via 
a heat-mediated stripping step, while the covalently bound fluorophore or chromogen 
remains bound to the epitope. The secondary antibody of this assay utilizes horseradish 
peroxidase (HRP) to catalyze the covalent bond between tyramide-fluorophore conjugate 
through spatial deposition to tyrosine molecules in close spatial proximity to the primary-





mIHC with TSA protocol in FFPE tissue is called the Opal Method and developed by 
Akoya Biosciences, previously part of Perkin Elmer (Parra, 2018).  The Opal method 
therefore allows for multiplexing with primary antibodies derived from the same host 
species. In numerous studies the Opal Method is confirmed as being reproducible and 
expressing individual fluorescent signals that correlate with its expression when 
developed in a monoplex assay (Stack et al., 2014).  
 
Linear Multispectral Unmixing to Maximize Signal to Noise Ratios and Removal of 
Tissue Autofluorescence  
 
A technological requirement for multispectral development of Opal fluorophores 
is “unmixing.” “Unmixing” facilitates the separation of the unique spectra of interest. To 
unmix multiplexed images, first a spectral library should be developed. The spectral 
library represents all of the individual emission spectra of each fluorophore. Using this 
data, a multiplexed image  may be unmixed through linear unmixing, which is a least 
square fit or linear regression mathematical model to visualize the intensity from each 
opal fluorophore individually without influence from adjacent spectrally similar 
fluorophore adjacent to it on the emission spectra (Mansfield, 2014). Another 
requirement of fluorescent mIHC is to remove the inherent autofluorescence in FFPE 
tissues. Because this autofluorescence may span the emission spectra of multiple 
fluorophores used in the multiplex, positive signal may be distorted (Mansfield, 2014) 






Whole slide Imaging (WSI) IA 
Paralleling the advancement of multiplex tissue staining is the technological 
advancement of whole-slide imaging (WSI), which entails digitally capturing images of 
entire histologic sections. This has resulted in the technological partnering of computer 
science and WSI platforms that precipitated the advent of digital pathology (DP) and IA.  
The application of DP images is diverse, ranging from facilitating telemedicine to 
enabling unbiased IA and quantitative outputs of pathology (Webster & Dunstan, 2014). 
As pathology was traditionally based on the qualitative descriptions by a pathologist, 
whole-slide digital images allow for integration of computational workflows including a 
diverse array of artificial intelligence software solutions including both machine and deep 
learning applications to quantitatively analyze entire slides of tissues in an unbiased and 
precise manner (Webster & Dunstan, 2014).  
The precision of IA comes from its potential to identify significant biological 
differences indiscernible to a trained pathologist using the human eye. Although 
pathologists have developed semi-quantitative metrics such as ordinal scoring of 
inflammatory processes, automated, continuous quantitative data can characterize subtle 
differences between groups and mitigate interobserver variability (Webster & Dunstan, 
2014). Regardless of the analysis tool used, it is vital for a trained pathologist to review 
automated algorithms to ensure tissues and unique cellular phenotypes are accurately 
identified.  
Today, the pharmaceutical industry and academic research centers are the primary 





utilized in the field of immuno-oncology, where quantitative and spatial information 
about healthy tissue, tumors margins, and immunomodulatory signals offers valuable 
insight into pathology and immune responses (Koelzer, Sirinukunwattana, Rittscher, & 
Mertz, 2019). Coupling the flexibility and capacity for high plex panel development, 
TSA mIHC in partnership with whole slide imaging and IA offers a unique tool to 









Mice and Mycobacterium avium infection 
B6 and B6.Sst1S strains of mice were used in a comparison experiment and 
infected with 10^5 M. avium (strain 101) by left intratracheal inoculation. Mice were 
sacrificed at three time points: 12, 16, and 21 wpi. After euthanasia, mouse lungs were 
perfused with PBS/Heparin followed by perfusion with 4% paraformaldehyde and 
inflation with 1% agarose.  
Multimodal Imaging Platform 
We employed an integrated multi-modal imaging platform to characterize the 
granulomatous lesions that characterize mycobacterium infections. A targeted histology 
approach was initiated by using MRI coordinates to dictate the depths at which formalin 
fixed paraffin embedded (FFPE) lung samples were sectioned in an effort to characterize 
the most salient lesions observed by the former and to investigate for imaging modality 
correlates. Furthermore, post-fixation shrinkage of tissue was accounted for when 
performing microtomy, enabling us to confidently obtain two-dimensional representation 
histologic tissue sections of interest. Since interpretation of MRI images at 12, and 16 
WPI displayed no evidence to suggest the presence of discrete necrotizing granulomas,  
lungs were cut 1 mm and 2 mm with a Leica RM2255 Microtome. Pulmonary pathology 
progressed at 21 WPI, and thus tissue sectioning was more targeted using specific MRI 
coordinates. However, mIHC analysis for the 21 wpi specimens is still forthcoming as of 






Brightfield Histopathological Preparation and Evaluation 
The lungs were then fixed for 48 hours in 10% neutral-buffered formalin. Tissues 
were treated with a tissue processor and 5 μm FFPE lung tissue were cut using a Leica 
RM2255 Microtome and transferred to positively charged slides. The slides were then 
deparaffinized in xylene, rehydrated in graded ethanol dilutions, and washed in water 
using a Leica ST5010 Autostainer XL. A subset of slides from each sample were stained 
with hematoxylin and eosin (H&E) using an established protocol on the Leica ST5010 
Autostainer XL. Following staining with H&E, slides were mounted using the Leica 
CV5030 Fully Automated Glass Coverslipper.  
Histopathologic Semi-Quantitative Analysis 
Dr. Nicholas Crossland, a board-certified veterinary pathologist, performed 
histopathological scoring of each whole lung specimen, while blinded to the mouse strain 
for each specimen. Ordinal scoring was based on the total area of lymphocytic and 
granulomatous inflammation as well as degree and/or absence of necrosis. This 
histopathological analysis and scoring provided a morphologic correlate for mIHC data. 
This afforded for the confirmation or ruling out of anticipated pathologies and 
characterization of pulmonary disease not attributed to M. avium (i.e., Eosinophilic 













0 No significant pathology observed 
1 Minimal focal-to- rare multifocal lymphohistiocytic inflammation; 
perivascular/peribronchiolar lymphocytic cuffing. Rare to scattered 
granulomatous foci with reactive macrophages. (<10% parenchyma affected) 
2 Mild-to-moderate multifocal lymphohistiocytic inflammation; 
perivascular/peribronchiolar lymphocytic cuffing. (>10-30% parenchyma 
affected)-rare single cell necrosis 
3 Moderate-to-marked multifocal lymphohistiocytic inflammation with rare 
single cell necrosis, scattered neutrophils and frequent swollen reactive 
histiocytes containing abundant lacy eosinophilic cytoplasm; perivascular and 
peribronchial lymphocytic cuffing. (>30-50% parenchyma affected) 
4 Discrete areas of caseating necrosis at the center of granulomatous 
inflammation with or without fibrous encapsulation. 
 







Fluorescence mIHC with TSA was conducted following Akoya Bioscience’s Opal 7-
color Manual IHC Kit User Manual and instruction from the Opal Assay Development 
Guide to inform optimization of the multiplex assay (Perkin Elmer Phenoptics Research 
Solutions).  6-plex IHC panels were optimized on mouse lung tissue infected with M. 
avium. Samples were prepared using the same tissue processing and deparaffinization 
protocols used for H&E histomorphological analysis. Antibodies included the following 
antigen targets: M.tb which cross-reacts with M. avium, CD3-T cells, and three 
macrophage markers (CD68, iNOS, & Arginase-1) to identify macrophage phenotypes 
involved in the host response to pulmonary infection by M. avium (Table 5).  
An overview of the Opal Method is provided in figure 2. All sections were fixed 
in 10% neutral buffered formalin for 20 minutes to help retain cellular structure prior to 
antigen retrieval. Antigen Retrieval (AR) (referred to as “microwave treatment” in figure 
2) was conducted in a BioCare Medical DeCloaking Chamber. Tissues underwent HIER 
using either AR buffer at pH of 6 (AR6) or pH of 9 (AR9), per instructions from the 
manufacturer. AR settings were dependent on the primary antibody’s manufacturer's 
instructions or additional AR optimizations experiment that were conducted. Prior to 
primary antibody incubation, tissues were blocked for 10 minutes to quench endogenous 







Figure 2: Opal Workflow schematic (Perkin Elmer Phenoptics Research Solutions) 
Prior to initiating an mIHC assay, optimizations experiments were conducted to 
determine primary antibody dilution, sequential order of primary antibody development, 
and assignment of each primary antibody to an Opal fluorophore. For the mIHC 
optimization, lung tissue derived from a B6.Sst1S, IFNβ YFP mice, which have YFP as a 
reporter for IFNβ expression, were infected with M. avium 10^6 (strain 101) intranasally 
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Optimization Step 1: Primary Antibody titration & incubation conditions 
For each primary antibody, three single-plex IHC slides were stained with the 
manufacturer’s recommended dilution, with two additional ten-fold serial dilutions. All 
single-plex fluorescent slides were developed with Opal 520. Fluorescent images were 
then analyzed qualitatively to determine optimal primary antibody titration that 
maximized positive signal to background noise ratios. Based on results of our single-plex 
experiments and reported conditions of these antibodies in the literature, select antibodies 
underwent additional single-plex testing to optimize duration and temperature of primary 
antibody incubation and AR parameters (temperature, duration, and buffer).  
Optimization Step 2: Determining optimal sequence order of epitope development 
Acknowledging that multiple sequential AR steps may variably affect (enhance or 
diminish) the availability of different epitopes, three monoplex slides, developed with the 
conditions determined in optimization step 1, were developed by either being exposed to 
1, 3, or 6 AR treatments. Signal to noise ratios were quantitatively determined by using 
the automated exposure time setting on a Nikon Ti2 inverted fluorescent microscope, 
with results reported as the mean of three, 200x magnification regions of interest. Since 
this automated exposure time feature aims to minimize exposure times, a faster exposure 
time is positively correlated with a stronger signal. As shown in figure 3, epitopes for 
CD3, M. tb, iNOS, were unmasked (enhanced signal) while Arginase-1 and CD68 were 






Figure 3: Antigen Retiral steps variably affected epitope signals  
Optimization step 3: Establishing rational sequence of antibody development 
Establishing a rational sequence of antibody immunostaining is crucial because 
different sequences can change signal intensity (Perkin Elmer Phenoptics Research 
Solutions). We considered three concepts in finalizing our antibody sequence. The first 
consideration was how multiple AR treatments variably affect epitope signals, as 
discussed above. Based on this data from figure 3, we concluded the Arg1 and CD68 
epitope expression was relatively constant and could therefore be developed earlier in the 
assay. Conversely, percentage decrease for the epitopes for iNOS, CD3, and M.tb were 
68%, 55%, and 65%, respectively, which indicated these should be developed later in the 
assay to maximize signal intensity.  
The second concept relevant to finalizing antibody order was determining which 
antibody would be developed last and paired with Opal 780. Opal 780 is a unique 
fluorophore in that it is conjugated with an antibody and therefore must be used after the 
last AR step in a multiplex assay. On the Vectra Polaris Automated Quantitative 





the same fluorophore concentration, as other Opal dyes. Therefore we reasoned to assign 
Opal 780 with a highly expressing molecular target, like M.tb. Therefore, after 
considering epitope stability and Opal 780 assignment, our order was: Arg1, CD68, 
iNOS, CD3, M.tb.  
Table 6: Opal Fluorophore brightness (Adapted from Perkin Elmer Phenoptics 
Research Solutions.  
Opal Fluorophore  Vectra Polaris Color Intensity 
Opal 480 Highest 
Opal 520 Highest 
Opal 570 Medium 
Opal 620 Medium 
Opal 780 Lowest 
 
The third concept we considered in determining the order of assay development 
was the “umbrella effect,” also called interference. The umbrella effect refers to the risk 
that overstaining with an opal TSA conjugated fluorophore may block later application of 
other Opal TSA conjugated fluorophores due to spatial inhibition of tyramide molecules 
(Perkin Elmer Phenoptics Research Solutions). In considering this effect, we reasoned 
that since CD68 is a pan-macrophage marker, it should be developed after iNOS, which 





plex assays where CD68 and iNOS were developed either first or second with 
interference then examined. We determined that the order of these two macrophage 
markers did not affect the staining around areas of granulomatous inflammation.  We 
therefore concluded that the order of the multiplex assay would be as follows: Arg1, 
iNOS, CD68, CD3, M.tb.  
 
Optimization step 4: Assignment of Opal Fluorophore to each primary  
Opal Fluorophore-Antibody pairing was determined by assigning epitopes with 
relatively low expression to Opal fluorophores with relatively high brightness given the 
same concentration on the Vectra Polaris (Table 6). In addition, we mitigated spectral 
crosstalk, or interference from spectrally adjacent fluorophores, by not assigning adjacent 
fluorophores to epitopes anticipated to localized within similar anatomical sub 
compartments.  
 
Optimization step 5: Opal Fluorophore titration 
 
Determining the titration of each fluorophore was evaluated by developing three 
6-plex assays, with each assay receiving for each given Opal Fluorophore either the 
manufacturer’s recommended titration, half the recommendation, or double the 
recommendation, Therefore three 6-plex assays were developed, with either relatively 
concentrated, manufacturer recommended, or dilute Opal fluorophores. It is 





prevent unmixing artifacts and spectral crosstal (Perkin Elmer Phenoptics Research 
Solutions).After imaging multiplex slides with the Vectra Polaris and unmixing with 
InForm (steps outlined below), signal intensity in three areas of granulomatous 
inflammation were recorded for each Opal Fluorophore using Phenochart, a whole slide 
contextual viewer (Akoya Biosciences). Results from this assay led us to use the 
relatively concentrated titration for each fluorophore except for Opal 480, for which we 
used the relatively dilute concentration.  
 
Whole Slide Scanning and Unmixing with Inform 
 
mIHC slides were digitized at 200x using the Vectra Polaris Automated 
Quantitative Pathology Imaging System (Akoya Biosciences). Exposure times were 
determined by using the auto-exposure feature at ROI on terminal, B6.Sst1S stain mouse 
tissue samples. Remaining slides were batch loaded and digitized using the same 
exposure time parameters.  Unmixing and removal of tissue autofluorescence was done 
using InForm (Akoya Biosciences). A pre-generated spectral library of the 5 Opal 
fluorophores used in the multiplex was used to spectrally unmix images. To remove 
tissue autofluorescence, we used a control autofluorescence slide that was not stained 
with DAPI or any Opal Fluorophore, but exposed to all AR treatments. Using the Manual 
Analysis feature of InForm, areas of autofluorescence were manually annotated, 






Image Analysis (IA)  
 
Digitized whole slides were analyzed using the image analysis software, Halo 
(Indica Labs, Inc., Corrales, NM). Each slide was manually annotated to denote left and 
right lung lobes and remove tissue artifacts (tissue folds or fluorescent precipitates) or in 
the case of two slides, small areas of the left caudal lung lobe with non-specific Arg1 
expression resulting from eosinophilic crystalline pneumonia. Threshold values for each 
fluorescent dye were modified to create uniform view settings for the 16 wpi and 12 wpi 
samples. Quantitative outputs were derived from the Tissue Classifier (TC), Highplex 
(HP), and Spatial Analysis Halo modules. TC is a train-by-example machine learning 
algorithm that uses a Random Forest hierarchical decision tree approach to automatically 
identify areas of tissue based on fluorescent color and contextual tissue features. For the 
TC, granulomatous lesions were identified as areas of colocalization with M. avium 
(denoted by Opal Fluorophore assigned to M. tb primary antibody, henceforth referred to 
as M. avium) and iNOS expressing macrophages. Quantitative outputs from TC data 
included the number of granulomatous lesions identified and area of these lesions.  
 The Halo HP module allows for simultaneous analysis of an unlimited number of 
fluorescence markers regardless of cellular compartment. Quantitative outputs for the HP 
module included absolute and percentage number of cells, and cellular phenotyping based 
on expression of fluorescent cytoplasmic markers. All cells were identified by using 
DAPI to segment individual nuclei. To phenotype individual cells, minimum cytoplasm 





were set using real-time tuning, starting with terminal Sst1S specimens and refining to 
accommodate fluorescence expression differences in the B6 specimens.  Due to 
significant divergence in expression between the 12 and 16 weeks-post-infection 
specimens, separate module parameters were set for the two time-points.  
 After cell segmentation was achieved using HP module, object data was given x-y 
coordinates and could then be spatially plotted. For spatial analysis features, we 







Figure 4: Halo IA Annotations & TC workflow. (A) Imported WSI scan in Halo, (B) 
Annotated WSI with right (green annotation) and left (yellow annotation) lung 
lobes, (C) 200x, Field of View unadjusted color channel intensity slide, (D) 200x, 
Field of View adjusted color channels to reduce background noise, (E) Train by 
example TC positive area of granulomatous inflammation (pink arrow) and 
negative area of granulomatous inflammation (green arrow), (F) Real-time viewer 
for TC module showing classified regions highlighted, finalized TC settings for 
16wpi specimens: resolution: 4.60 (um/px), Minimum object size: 100.00 (um^2). 
For 12wpi specimens, finalized settings: resolution: 4.00 (um/px), Minimum object 
size: 70.0 um^2. .  Color Key for all images: Purple= M. avium, Blue= iNOS, 







Figure 5: Halo IA High-plex and PA workflow. (A) 200x, Field of View with only 
DAPI channel, (B) 200x, Field of View, with real-time viewer used to adjust cell 
segmentation parameters based off nuclear DAPI staining, (C) 200x, Field of View, 
with only Opal 520 channel, (D) 200x, Field of view, with real-time viewer used to 
adjust cell segmentation parameters based off cytoplasmic fluorophore staining; this 
workflow (C-D) was followed for each Opal Fluorophore, (E) Results of Halo HP 





phenotype, (F) 200x, Field of View, for the corresponding Field of View in (E), (G) 
Halo Spatial Plot and PA output of iNOS+, M. avium + cells and Arg1+ cells, (H), 
200x, Field of view, PA output image of Arg1+ cells within 50 um of iNOS+, M. 
avium+ cell. All PA modules for Arg1+ cells and CD3+ cells were conducted 
uniformly across specimens with the following parameters: Measure CD+/Arg1+ 
cell within 50 um proximity of iNOS+, M. avium+. Color Key for all images: Purple= M. avium, Blue= 
iNOS, Green= CD3, Orange= CD68, Yellow = Arg1, Grey= DAPI.  
 
Figure 6: Halo Highplex Module parameters for 16 wpi specimens. (A) Nuclear 
detection parameters to segment individual cells, (B) Membrane and cytoplasm 
detection parameters to refine cell segmentation, (C) Positive nuclear threshold for 






Figure 7: Halo Highplex Module parameters for 12 wpi specimens (A) Nuclear 
detection parameters to segment individual cells, (B) Membrane and cytoplasm 
detection parameters to refine cell segmentation, (C) Positive nuclear threshold for 
DAPI, (D), Positive cytoplasm thresholds for each Opal fluorophore  
 
Statistical Analysis for mIHC 
The unpaired t-test was utilized given mIHC results were parametric and continuous to 
answer two questions. We first questioned whether there was a statistical difference 
between the inoculated and non-inoculated lung lobes of mice from each strain examined. 





signatures of disease in B6 and B6.Sst1S strains. The unpaired t test was often applied 
across multiple rows in Prism 8.0. These graphs show multiple unpaired t tests for each 
title on the x-axis. No correction for comparison among multiple groups was evaluated. 








Qualitative inspection of mIHC images confirmed a consistent morphomolecular 
signature from all specimens (Figures 8, 9). We observed areas of granulomatous 
inflammation with iNOS+ M. avium+ cells interwoven and surrounded by iNOS+ M. 
avium- cells. When comparing between mouse strains, M. avium staining intensity was 
qualitatively greater in B6.Sst1S lesions compared to B6 lesions. This appeared more 
pronounced in the non-inoculated lung lobe than in the inoculated lung lobes.  There 
were also iNOS- M. avium+ cells within areas granulomatous inflammation that were not 
phenotyped due to lack of colocalized staining with other biomarkers. Populations of 
CD3+ cells infiltrated areas of infection and were present in Bronchial Associated 
Lymphatic Tissue (BALT). Populations of CD68+ cells were dispersed throughout the 
lung interstitium and free within alveolar spaces. Arg1+ cells were most frequently found 
near bronchioles or incorporated within larger areas of granulomatous lesions containing 
iNOS+ M. avium+ cells. When incorporated within larger granulomatous lesions, Arg1+ 
cells appeared more swollen than when adjacent to bronchioles.  In summary, mIHC 
afforded us a tool to characterize three distinct macrophage markers (Arg1+, CD68+, 
iNOS+), T cells (CD3+ cells), and cells containing mycobacterium (M. avium+).  










Figure 8: Representative mIHC images of B6 non-inoculated lung lobe lesion in an 
experimental model of M. avium infection at 16 wpi. (A) Small and discrete 
granulomatous lesions, as recognized by Tissue Classifier (pink outline), B) Raw 
image of area of granulomatous inflammation without Tissue Classifier filter, (C) 
Colocalization of M. avium within iNOS+ cells within area of granulomatous 
inflammation, only M. avium and iNOS colors visible, (D) CD68+ cells and Arg1+ 
cells present in area of granulomatous inflammation, only M. avium, CD68, and 
Arg1 colors visible.  Color Key for all images: Purple= M. avium, Blue= iNOS, 













Figure 9: Representative mIHC images of B6.Sst1S Non-inoculated lung lobe lesion 
in a susceptible model of M. avium infection at 16 wpi. (A) Large area of 
granulomatous lesion, as recognized by Tissue Classifier (pink outline), and 
adjacent area with high density of CD3+ cells, (B) Raw image of area of 
granulomatous inflammation and adjacent area with high density of CD3+ cells, 





colocalized with iNOS+ cells in area of granulomatous inflammation, only M. avium 
and iNOS colors visible, (D) CD68+ cells and Arg1+ cells present mostly around 
central area of M. avium expression, only M. avium, CD68, and Arg1 colors visible. 
Color Key for all images: Purple= M. avium, Blue= iNOS, Green= CD3, Orange= 




Quantitative Outputs  
Halo™ IA software was used to generate quantitative outputs of the immune response to 
our experimental model M. avium infection. Table 7 offers a summary of IA tools used 
generate outputs.  
Table 7: Halo™ IA Modules used and corresponding regions evaluated and quantitative outputs.  
Halo™ IA Module Region Studied Quantitative Output 
Tissue Classifier (TC) Inoculated & Non-
inoculated lung lobes 
Area of immunoreactivity 
defined as granulomatous 
lesions 
Highplex cell (HP) 
segmentation 
Inoculated lung lobes, non-
inoculated lung lobes, 
granulomatous lesions in 
non-inoculated lung lobes 
(defined by Tissue 
classifier)  
Percentage of cell 
phenotype; 
# of cells within TC regions 
Proximity Analysis Non-inoculated lung lobes Percentage of CD3+ and 
Arg1+ within 50 µm of M. 
avium+, iNOS+ cells 
Nearest Neighbor Analysis  (1) Non-inoculated lung 
lobes, (2) granulomatous 
lesions in non-inoculated 
lung lobes (defined by 
Tissue classifier) 
(1) Average distance 
between nearest CD3+ cell 
and every iNOS+  M. 
avium+, cell  
(2) Average distance 
between nearest CD3+ cell 
and every Arg1+ cell; 
average distance between 
nearest CD3+ cell and every 





Differentiating Primary and Secondary Lesions 
To differentiate between primary lesions (initial sites of infection) and secondary lesions 
(metastasized sites of infection) we assumed that the inoculated (left) lung lobes contain a 
mix of primary and secondary lesions, and the non-inoculated (right) lung lobes contain 
mostly secondary lesions. Although this assumption is limited by our suspicion of 
primary lesions adjacent to bronchioles of the non-inoculated lung lobes, we did observe 
meaningful differences upon comparing immunophenotyed cells between lung lobes. In 
comparing the expression of immunophenotyed cells between lung lobes, we gathered 
insight into the cellular signatures differentiating primary and secondary pulmonary 
lesions.  
 In comparing the expression of immunophenotyped cells across the entire 
inoculated and non-inoculated lung lobes, we observed signatures consistent with an 
increased immune response in the inoculated lung lobes. At representative sections 
among all DAPI nuclei segmented cells (henceforth referred to as segmented cells) there 
was a greater percentage of CD3+, M. avium+, and iNOS+ cells in the inoculated lung 
lobes compared to the non-inoculated lung lobes at 12 wpi (Supplemental Figure 1, 2). 
Although these results were not statistically significant, the trend was consistent at 16 
wpi. There were no differences in percent expression of Arg1+ and CD68+ cells between 
lung lobes in this comparison at 12 wpi. Consistent with our understanding of the 
temporal delay of secondary lesion formation, we observed enhanced differences 






  At 16 wpi, we first noticed statistically significant differences in percentage of 
immunophenotyped cells between the inoculated and non-inoculated lung lobes. 
Consistent with findings from 12 wpi, there was evidence of increased expression in the 
inoculated lung lobes of CD3+, M. avium+, and iNOS+ cells, however no difference in 
CD68+ cell expression (Figure 10). Although the mean percentage of Arg1+ cell 
expression was greater in the inoculated lung lobes of both strains at 16 wpi, there was a 
high degree of variability between animals.  
 At 16 wpi, we also analyzed HP quantitative outputs for phenotyped macrophages 
including iNOS+ M. avium+ cells, iNOS+ M. avium- cells, and iNOS- M. avium+ cells 
(Figure 10). There was a greater percent expression of iNOS+ M. avium- cells in 
inoculated lung lobes compared to the non-inoculated lung lobes of B6 mice. This 
difference was not evident in B6.Sst1S mice. We hypothesize two explanations for the 
existence of iNOS+ M. avium- cells. These phenotypes may in fact express M. avium at a 
level below the standardized positivity threshold, or they could represent macrophages 
induced to express iNOS from paracrine cytokine signaling. B6.Sst1S mice contained 
elevated percent expression of iNOS+ M. avium+ cells and iNOS-, M. avium+- cells in 
inoculated lung lobes compared to non-inoculated lung lobes. Further HP workup is 
necessary to determine if these cells are positive for Arg1 or CD68. These cells should 






Figure 10: Highplex Quantitative image analysis between inoculated and non-
inoculated lung lobes of an experimental model of M. avium infection in B6 and 
B6.Sst1S mice at 16 wpi. (A) Inoculated lung lobes of B6 mice showed elevated 
expression of CD3+ cells, iNOS+ cells, and iNOS+, M. avium – cells, compared to the 
expression of each biomarker or phenotype in the non-inoculated lung lobes, (B) 
Inoculated lung lobes of B6.Sst1S mice showed elevated expression of CD3+ cells, M. 





expression of each biomarker or phenotype in the non-inoculated lung lobes. All 
cells were segmented by DAPI+ nuclei. Biomarker expression determined by 
fluorophore staining in cytoplasm. Quantitative output of % cell type determined by 
“x”+ cell type/ all DAPI+ cells in given lung lobe.  Comparison Statistical 
significance determined without correction for multiple comparisons, with 
alpha=0.05. Each marker on the x-axis was analyzed individually, without assuming 
a consistent SD. Number of t tests: 8 
While whole lung lobe analysis of immunophenotyped cells showed meaningful 
differences in cell biomarkers and phenotypes between inoculated and non-inoculated 
lung lobes, it also has limitations. The primary limitation was that a number of our 
biomarkers, such as CD68, CD3, and Arg+, were present in areas of the lung that did not 
display pathology markers such as M. avium or iNOS. For example, CD3+ cells were 
congregated in areas of BALT, and Arg1+ cells were present around bronchioles. To 
specify HP analysis to areas of granulomatous inflammation, we employed the TC 
module to automatically recognize areas with iNOS+ and M. avium+ colocalization as 
“granulomatous lesions.”  Images of this classification is also presented in Figures 8(A) 
and 9(A). By computing HP data only in these classified granulomatous lesions, analysis 
was specified to differentiate features between nascent granulomatous lesions in 
inoculated (mostly primary lesions) versus non-inoculated lung lobes (mostly primary 
and secondary lesions). Example TC lesion and HP cell segmentation work-up image is 






Figure 11:  Representative image of cell populations within Tissue Classifier 
recognized granulomatous lesion in the non-inoculated lung lobes of B6.Sst1S mice 
at 16 wpi. (A) Raw-image of cell population within area of granulomatous lesion, (B) 
High-plex (HP) cell segmentation of cellular phenotypes within granulomatous 
lesion; HP based off DAPI+ nuclei cell segmentation. Solid pink line represents 
granulomatous lesion boundary and dotted pink line is excluded area. Color Key for 
Raw image (A): Purple= M. avium, Blue= iNOS, Green= CD3, Orange= CD68, 
Yellow = Arg1, Grey= DAPI. All images digitalized at 200x.  
 
 In order to evaluate biomarker and cell phenotype expression, while controlling 
for level of infection, we devised an “infection ratio” equation. This standardized HP cell 
outputs for level of infection present within granulomatous lesions in each mouse. The 
infection ratio was calculated by dividing the number of a given cell phenotype in total 
area of TC lesions by the number of iNOS+ M. avium+ cells in the same total area of TC 
lesions. Interestingly, in B6 mice, the CD3+ cell infection ratio was greater in non-
inoculated lung lobe lesions than in inoculated lung lobe lesions (Figure 12). This 
relationship was equal or slightly reversed in B6.Sst1S mice, but not to a statistically 





lesions in B6 mice compared to B6.Sst1S mice. This relationship is further investigated 
in the next section and Figure 15. Although not statistically significant, we also that 
inoculated lung lobes had elevated infection ratios of iNOS+ M. avium- cells compared to 
non-inoculated lung lobes.  
 We also investigated the infection ratios for a number of other macrophage 
phenotypes between lesions in the inoculated and non-inoculated lung lobes of both 
strains (Supplemental Figure 3). There were no statistically significant differences 
between these comparisons. However, we found lesions in the non-inoculated lung lobes 
of B6 mice had a larger infection ratio of the CD68+ M. avium+ iNOS- macrophage 
phenotype than lesions in the inoculated lung lobe. This relationship was reversed when 
comparing this infection ratio in lesions of inoculated and non-inoculated lung lobes in 
B6.Sst1S mice. In summary, we analyzed cell phenotype data between inoculated and 
non-inoculated lung lobes to investigate features of primary and secondary lesions. In 
whole lung lobe HP analysis, we found that elevated iNOS and M. avium expression were 
associated with inoculated lung lobes. Within granulomatous lesions, however, we found 
that in B6 mice there was a greater ratio of CD3+ cells to iNOS+ M. avium+ cells 






Figure 12: Highplex Quantitative image analysis of cell types within Tissue 
Classifier recognized granulomatous lesions in the inoculated and non-inoculated 
lung lobes of an experimental model of M. avium infection in B6 and B6.Sst1S mice 
at 16 wpi. (A) Cell populations within granulomatous lesions of the non-inoculated 
lung lobes in B6 mice showed increased CD3+ infection ratio than the CD3+ 
infection ratio in the inoculated lung lobes, but there was no difference in infection 
ratio for Arg1+, CD68+, or iNOS+, M. avium- cells, (B) No statistical difference in 
infection ratios between granulomatous lesions in inoculated and non-inoculated 
lung lobes of B6.Sst1S mice. All cells were segmented by DAPI+ nuclei. Infection 
ratio was determined by “x”+ cell type in TC lesions/ iNOS+, M. avium+ cells within 
area TC lesions. Biomarker expression determined by fluorophore staining in 
cytoplasm. Quantitative output of # cells determined by “x”+ cell type in 
granulomatous lesions of the given lung lobe. Comparison Statistical significance 
determined without correction for multiple comparisons, with alpha=0.05. Each 
marker on the x-axis was analyzed individually, without assuming a consistent SD. 





Identifying immune correlates of resistance and susceptibility in lung sections 
 Given our assumption that pulmonary lesions in non-inoculated lung lobes represent 
secondary lesions that develop due to sst1 mediated susceptibility, while lesions in the 
inoculated lung lobes represent sites of primary lesions, we hypothesize that evidence of 
sst1 mediated susceptibility would be exhibited differently in the inoculated and non-
inoculated lung lobes.  
 At 12 wpi, we did not find convincing evidence of sst1 mediated susceptibility 
through HP analysis in the inoculated or non-inoculated lung lobes (Supplemental Figure 
4, 5). At 12 wpi, there was a trend of increased percentage of Arg1+ cells in the 
inoculated and non-inoculated lung lobes of B6.Sst1S mice (Supplemental Figure 4, 5). 
Lack of statistical difference in HP outputs between B6 and B6.Sst1S strains at 12 wpi 
suggests that this time point was too early in the infection course to appreciably notice 
evidence of sst1 susceptibility with our methodology or that differences develop at later 
time points.  
Supporting our hypothesis, at 16 wpi there was evidence of sst1-mediated 
susceptibility in the non-inoculated lung lobes using whole lung lobe HP analysis. By 
comparing immunophenotyped cells in the non-inoculated lung lobes of B6 and B6.Sst1S 
mice, there was evidence of increased percent M. avium+ cell expression in B6.Sst1S 
mice (Figure 13). However, no difference was found in the inoculated lung lobes (Figure 
13). Percent expression of iNOS+ M. avium+ was higher in B6.Sst1S mice in both lung 
lobes compared to B6 mice. Percent expression of iNOS- M. avium+ cells was also 





statistically significant in the non-inoculated lung lobes. Interestingly, the percent 
expression of iNOS+ M. avium- was elevated in the inoculated lung lobe of B6.Sst1S 
mice compared to B6, but not in the non-inoculated lung lobe.  
Taken together, our data suggest that sst1 mediated susceptibility is associated 
with elevated iNOS- M. avium+ cells in secondary lesions of B6.Sst1S mice, iNOS+ M. 
avium+ cells in both primary and secondary lesions of B6.Sst1S mice, and decreased 
iNOS+ M. avium- cells in primary lesions in B6.Sst1S mice. Our findings are also 
suggestive of sst1 mediated susceptibility mediated through both lung lobes, but 
predominately in the non-inoculated lung lobe. Further statistical analysis of cell 
phenotypes is necessary to confirm this finding. Although subtle, a conserved trend from 
12 wpi was observed showing slightly elevated percent expression of Arg1+ cells in 
B6.Sst1S mice compared to B6, but this was not statistically significant. There was no 
statistically different CD68+ and CD3+ cells when making comparisons between the 
same lung lobes of different strains (Figure 13). To analyze differences within 
granulomatous lesions, we also investigated cell biomarkers and cell phenotypes within 










Figure 13: Highplex Quantitative image analysis between B6 and B6.Sst1S mice in 
an experimental model of M. avium infection at 16 wpi. (A) Inoculated lung lobes of 
B6.Sst1S mice showed increased percent cell expression of iNOS+, M. avium+ cells 
and decreased expression of iNOS+, M. avium- cells compared to percent expression 
of corresponding phenotypes in inoculated lung lobes from B6 mice, (B) Non-
inoculated lung lobes of B6.Sst1S mice showed increased percent cell expression of 
M. avium+, iNOS+ M. avium+, and iNOS- M. avium+ cells compared to percent 
expression of corresponding biomarkers or cell phenotypes in non-inoculated lung 
lobes from B6.Sst1S mice. All cells were segmented by DAPI+ nuclei. Biomarker 
expression determined by fluorophore staining in cytoplasm. Quantitative output of 





lobe.  Comparison Statistical significance determined without correction for 
multiple comparisons, with alpha=0.05. Each marker on the x-axis was analyzed 
individually, without assuming a consistent SD. Number of t tests: 8. 
 To identify cell phenotypes within granulomatous lesions that influence 
susceptibility, we employed HP analysis to segmented cells within TC recognized 
lesions. To standardize cell expression to level of infection, we again calculated infection 
ratios by diving the total number of a given “x” +cell in TC lesion area by number of 
iNOS+ M. avium+ cells within the same TC lesion area. Our findings were consistent 
with our hypothesis that sst1 mediated susceptibility would be evident in non-inoculated 
lung lobes to a greater degree than inoculated lung lobes. We found statistically increased 
CD3+ infection ratio and iNOS+ M. avium- in lesions within the non-inoculated lung 
lobes of B6.Sst1S mice compared to B6 mice. Trends were consistent when making this 
comparison in lesions within inoculated lung lobes, however not statistically significant 
in regard to CD3+ infection ratio. There was no observed difference in the infection 








Figure 14 Highplex Quantitative image analysis of cell types within Tissue Classifier 
recognized granulomatous lesions in B6 and B6.Sst1S mice in an experimental 
model of M. avium infection at 16 wpi. (A) Cell populations within granulomatous 
lesions of the inoculated lung lobe in B6.Sst1S showed decreased iNOS+ M. avium- 
infection ratio when compared to the corresponding infection ratio in 
granulomatous lesions of the inoculated lung lobe in B6 mice, (B) Cell populations 
within granulomatous lesions of the non-inoculated lung lobe in B6.Sst1S showed 
decreased CD3+ cell and iNOS+ M. avium- infection ratios compared to the 
corresponding infection ratios in granulomatous lesions of the non-inoculated lung 
lobe in B6 mice. All cells were segmented by DAPI+ nuclei. Infection ratio was 
determined by “x”+ cell type within TC lesions/ iNOS+, M. avium+ cells within TC 
lesions. Biomarker expression determined by fluorophore staining in cytoplasm. 
Quantitative output of # of cells determined by “x”+ cell type within granulomatous 
lesions/ all DAPI+ cells in granulomatous lesions of the given lung lobe. Comparison 





with alpha=0.05. Each marker on the x-axis was analyzed individually, without 
assuming a consistent SD. Number of t tests: 4. 
 Supplemental figure 6 highlights that the predominant macrophage phenotypes 
within granulomatous lesions of the non-inoculated lung lobes were iNOS+ cells. There 
were minimal double positive iNOS+, Arg1+ macrophages, as well as minimal M. 
avium+ Arg1+ or M.avium+ CD68+ macrophages. Supplemental figure 7 highlights 
infection ratios for other macrophage phenotypes. Although there was no statistical 
difference, there was a slightly elevated infection ratio of the CD68+ M. avium+ iNOS- 
macrophage phenotype within lesions of the non-inoculated lung lobes of B6 compared 
to B6.Sst1S mice. Further HP quantitative analysis is necessary to determine correlates of 
increased presence of this macrophage phenotype. In conclusion, when analyzing HP 
outputs from all areas classified as granulomatous lesions at 16 wpi, the cell phenotypes 
that showed the most variability between strains was iNOS+ macrophages and CD3+ T 
cells.   
Identifying spatial patterns of T cells and M2 Macrophages in the context of Sst1 
mediated susceptibility   
Given the classical M2 paradigm that Th2 cytokines, Il-4 and Il-13, induce Arg1 
expression in macrophages (Wynn 2003), we analyzed HP and spatial analysis data of 
Arg1+ and CD3+ cells to investigate the role of M2 macrophage and, indirectly, 
potentially gain insight into the Th2 immune response in our experimental model. While 
qualitatively, we observed Arg1+ cell expression around larger granulomatous lesions, 
we did not observe an increased Arg1+ infection ratio in B6.Sst1S mice (figure 14). 
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However, we have not yet analyzed correlation data between TC lesion size and Arg1+ 
cell expression. To investigate the relationship of Arg1+ cells and CD3+ cells, the ratio 
of Arg1+ cells to CD3+ cells within TC lesions was calculated. We hypothesized this 
could serve as an indirect indication of a Th2 immune response. Although not statistically 
different, there was an elevated Arg1:CD3 ratio in lesions from both lung lobes of 
B6.Sst1S mice compared to B6 mice. Moreover, the inoculated lung lobes of both strains 
also exhibited an elevated Arg1:CD3 ratio (Figure 15). There was a large amount of 
variation between Arg1:CD3 ratio between mice, and further analysis should consider 
correlates of elevated Arg1:CD3 ratios within granulomatous lesions of different sizes. 
Figure 15: Highplex Quantitative image Analysis of Arg1+ cell and CD3+ cell 
relationship in Halo Tissue Classifier recognized granulomatous lesions in an 
experimental model of M. avium infection using B6 and B6.Sst1S mice at 16 wpi. (A) 
In both the inoculated and non-inoculated lung lobes, the mean Arg1+ cell/ CD3+ 
cell ratio was slightly elevated in granulomatous lesions of  B6.Sst1S mice compared 
to B6, (B) In both the B6 and B6.Sst1S strain, the mean Arg1+ cell/ CD3+ cell ratio 
was slightly elevated in granulomatous lesions in the inoculated lung lobes 
compared to the non-inoculated lung lobes. However, in both graphs, there is large 
variation between specimens. All cells were segmented by DAPI+ nuclei. Arg1/CD3 
ratio was determined by Arg1+ cells within TC lesions/ CD3+ cells within TC 





Comparison Statistical significance determined without correction for multiple 
comparisons, with alpha=0.05. Each marker on the x-axis was analyzed 
individually, without assuming a consistent SD. Number of t tests: 2. 
To evaluate the spatial characteristics of Arg1+ cells to CD3+ cells we employed 
Nearest Neighbor spatial analysis to find the nearest CD3+ to every Arg1+ cell within TC 
lesions in the non-inoculated lung lobes of both strains. Although not statistically 
significant, the average distance between Arg1+ and CD3+ cells was shorter in B6.Sst1S 
non-inoculated lung lobe lesions compared to B6 non-inoculated lung lobe lesions 
(Figure 16, A). There was also increased percentage of Arg1+ cells within 50 μm of 
iNOS+ M.avium+ cells in the entire non-inoculated lung lobe of B6.Sst1S strain mice 
compared to B6 mice at 16 wpi (Figure 17). However, there was no difference in the 
inoculated lung lobes at 16 wpi, and no difference in either lung lobes at 12 wpi 
(Supplemental Figure 8). The limitation of this analysis is that if an iNOS+ M. avium+ 
cell was within 50 µm of an Arg1+cell found near a bronchiole, rather than part of a 
granulomatous lesion, the proximity distance would be artificially shortened.   
Interestingly, the distance between the nearest CD3+ to every iNOS+ M. avium+ 
cell  in TC lesions in the non-inoculated lung lobes was shorter in B6.Sst1S  mice 
compared to B6 (Figure 16, B). This implies that although the relative proportion of T 
cell help in granulomatous lesions is lower in B6.Sst1S mice when standardized for level 
of infection (Figure 14), T cells are not distanced further away from iNOS+ M. avium+ 
macrophages within those lesions.  
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Figure 16: Nearest Neighbor quantitative spatial image analysis of CD3+ cells to 
Arg1+ and iNOS+ M. avium+ cells in TC lesions in the non-inoculated lung lobes in 
an experimental model of M. avium infection using B6 and B6.Sst1S mice at 16 wpi.  
(A) The mean distance of the nearest CD3+ to every Arg1+ cell within
granulomatous lesions of the non-inoculated lung lobe is shorter in B6.Sst1S mice
than in B6 mice, (B) The mean distance of the nearest CD3+ to every iNOS+ M.
avium+ cell in granulomatous lesions of the non-inoculated lung lobe is shorter in
B6.Sst1S mice than in B6 mice, (C) Work up digitalized 200x image of Nearest
Neighbor Analysis of nearest CD3+ cell to every Arg1+ cell. Red dots= Arg1+ cells,
orange dots= nearest CD3+ cell to every Arg1+ cell, grey lines= distance measured.
Highplex data was generated by cell segmenting cells through DAPI+ nuclei within
Tissue Classifier recognized granulomatous lesions. Spatial plots of each
biomarker/phenotype were generated, and each cell was given an x,y coordinate to
facilitate Nearest Neighbor Spatial Analysis. Statistical significance determined with
unpaired t test, with alpha=0.05.
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Figure 17: Proximity Analysis quantitative spatial image analysis of Arg1+ cells 
within 50 μm of iNOS+ M. avium+ cells in inoculated and non-inoculated lung lobes 
in an experimental model of M. avium infection using B6 and B6.Sst1S mice at 16 
wpi. (A) No difference in percentage of Arg1+ cells within 50 μm of iNOS+ M. 
avium+ cell in the inoculated lung lobes of B6.Sst1S and B6 mice at 16 wpi, (B) 
Increased percentage of Arg1+ cells within 50 μm of iNOS+ M. avium+ cell in the 
non-inoculated lung lobes of B6.Sst1S comparted to B6 mice at 16 wpi. Y-axis was 
calculated by taking percent of Arg1+ cells within 50µms of iNOS, M. avium+ cells / 
all Arg1+ cells in given lung lobe. Highplex data was generated by cell segmenting 
cells through DAPI+ nuclei inoculated and non-inoculated lung lobes. Spatial plots 
of each biomarker/phenotype were generated and each cell was given an x,y 
coordinate to facilitate Proximity Analysis Spatial Analysis. Statistical significance 
determined with unpaired t test, with alpha=0.05.  B6.Sst1S contained 3 specimens 
and B6 mice contained 4 specimens.  
There are important limitations to the employed spatial analysis modules, and this 
will be discussed further in the discussion section. In brief, spatial analysis within TC 
lesions is partly compromised by the fact that distance measures are occasionally 
calculated between cell types of different lesions that are adjacent to each other. This was 
especially present near bronchioles or BALT, were TC lesion area were less continuous. 
A significant example of the importance of close inspection of spatial proximity outputs 
is that analysis of the nearest CD3+ cell to every iNOS+ M. avium+ cell when applied 
across the whole lung lobe, led to the opposite results as shown in Figure 16(B). In this 
output across the whole non-inoculated lung lobe, distance of CD3+ cells to iNOS+ M. 
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avium+ cells was greater in B6.Sst1S mice compared to B6 mice at 16 wpi (Figure 18). 
This could reflect the fact that CD3+ cells are farther away from iNOS+ M. avium+ cells 
outside of TC lesions than inside of lesions. However, further investigation of these 
spatial analysis parameters is required to draw conclusions.   
Figure 18: Nearest Neighbor quantitative spatial image analysis of nearest CD3+ to 
every iNOS+ M. avium+ cells in the non-inoculated lung lobes in an experimental 
model of M. avium infection using B6 and B6.Sst1S mice at 16 wpi. (A) The mean 
distance of the nearest CD3+ cell toe very Arg1+ cell in the non-inoculated lung lobe 
is longer in B6.Sst1S mice compared to B6 mice, (B) Work up digitalized 200x image 
of Nearest Neighbor analysis of nearest CD3+ to every iNOS+ M. avium+ cell. Blue 
dots= unique iNOS+ M. avium+ cells, Yellow dots= nearest CD3+ cell to every 
iNOS+ M. avium+ cell, grey lines= distance measured. Highplex data was generated 
by cell segmenting cells through DAPI+ nuclei within Tissue Classifier recognized 
granulomatous lesions. Spatial plots of each biomarker/phenotype were generated, 
and each cell was given an x,y coordinate to facilitate Nearest Neighbor Spatial 
Analysis. Statistical significance determined with unpaired t test, with alpha=0.05.    
While acknowledging these limitations, further spatial analysis outputs were 
conducted to characterize the spatial characteristics of Arg1+ and CD3+ cells. Through 
employing Proximity Analysis across entire lung lobes, we found increased percentage of 
CD3+ cells within 50 μm of iNOS+ M. avium+, cells in the non-inoculated lung lobe of 
B6.Sst1S mice compared to B6 mice at 16 wpi (Figure 19). There was no difference in 
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this output when making this comparison in the inoculated lung lobes at 16 wpi or in 
either lung lobes at 12 wpi (Supplemental Figure 9).  The limitation of this analysis is 
that iNOS+ M. avium+ cells within 50 µm of BALT would decrease the mean distance 
values. The proximity of iNOS+ M. avium+ cells to areas of BALT was not investigated. 
Figure 19: Proximity Analysis quantitative spatial image analysis of CD3+ cells 
within 50 μm of  iNOS+ M. avium+ cells in inoculated and non-inoculated lung lobes 
in an experimental model of M. avium infection using B6 and B6.Sst1S mice at 16 
wpi. (A) No difference in percentage of CD3+ cells within 50 μm of iNOS+ M. 
avium+ cell in the inoculated lung lobes of B6.Sst1S and B6 mice at 16 wpi, (B) 
Increased percentage of CD3+ cells within 50 μm of iNOS+ M. avium+ cell in the 
non-inoculated lung lobes of B6.Sst1S comparted to B6 mice at 16 wpi. Y-axis was 
calculated by taking percent of CD3+ cells within 50µms of iNOS, M. avium+ cells / 
all CD3+ cells in given lung lobe. Highplex data was generated by cell segmenting 
cells through DAPI+ nuclei inoculated and non-inoculated lung lobes. Spatial plots 
of each biomarker/phenotype were generated, and each cell was given an x,y 
coordinate to facilitate Proximity Analysis Spatial Analysis. Statistical significance 
determined with unpaired t test, with alpha=0.05.  B6.Sst1S contained 3 specimens 







Spatiotemporal Analysis of Immune Signatures of Pulmonary Granulomatous 
Lesions 
In this study we established mIHC coupled with IA as a tool to quantitatively characterize 
granulomatous lesions in a susceptible mouse model of M. avium infection. We found a 
pathologically meaningful effect of the sst1 locus on the susceptibility to M. avium 
infection and found unique cellular signatures in pulmonary lesions of B6.Sst1S mice. 
We also quantitatively characterized unique cell phenotypes that could be due to 
differences in cellular signatures between primary and secondary pulmonary lesions.    
Sst1 mediated susceptibility was statistically detectable at 16 wpi, but not at 12 wpi. This 
slow progression of sst1 susceptibility is consistent with the M. tb model in which 
organized granulomas with caseous necrotic centers are only evident after 9-12 wpi 
(Kramnik & Beamer 2016).   
Our qualitative findings of iNOS+, M. avium+ cells within areas of 
granulomatous inflammation and surrounded by CD3+ cells were consistent with 
previous literature employing a multiplex imaging modality to a murine model of 
mycobacterial infection (Carow et al., 2019).  This recent study using M. tb infection in 
C56BL/6 mice analyzed by mRNA in situ imaging, found that iNOS and CD68 mRNA 
localized in M. tb affected regions as early as 8 wpi (Carow et al., 2019). This study did 
not find a clear association between T cell proximity and M.tb, however it did observe 
increased CD3e signal in granulomas at later time points. In our study, we could not 





strains. We did, however, observe a decreased ratio of CD3+ cells to iNOS+ M. avium+ 
cells in granulomatous lesions of B6.Sst1S mice. This finding suggests that given the 
same level of infection, T cells were less involved in granulomatous lesions in susceptible 
mice.  
Carow et al (2019) examined the distinct localization of immune transcripts 
within three regions—inner, perimeter, and outer--of individual granulomas and found 
variable distribution of immune signals at different infection time points. Future research 
using Halo™ IA could analyze phenotyped cells with a similar methodology by 
employing the Infiltration Analysis (Halo™) module around TC lesions. This feature 
enables researchers to study the density of cell phenotypes within, on the border of, and 
outside a classified area. Additional research into the heterogeneity of pulmonary lesions 
in mycobacteriosis could foster insights into correlates of immune protection or 
pathology.  While we found unique cellular phenotypes among susceptible and wild type 
mouse strains, further analysis of spatial differences between macrophage phenotypes 
could provide increased insight into correlates of host immunity and mycobacterial 
disease progression.  
By analyzing the heterogeneity of granulomatous lesions within the same strain, 
we found evidence that at 16 wpi, inoculated lung lobes with primary lesions had greater 
percentages of CD3+, M. avium+, iNOS+ cell biomarkers. This implies that elevated 
levels of these biomarkers serve as correlates for early disease progression.  These trends 
were marginally present but not statistically significant at 12 wpi, implying that 





iNOS+ M. avium+ cells, we found evidence that iNOS+ M. avium- cells were associated 
with secondary lesions of both strains. Interestingly, this macrophage phenotype was 
statistically increased in the inoculated lung lobes of B6 mice compared to the non-
inoculated lung lobes. The fact that this relationship was reversed when computing its 
infection ratio to account for level of iNOS+ M. avium+ cells, suggests that iNOS+ M. 
avium- may be correlated to extent of infected cells.  
We also found evidence that iNOS- M. avium+ cells may be increased in primary 
lesions compared to secondary lesions of both strains. An infection ratio was not 
computed for this phenotype to control for level of iNOS+ M. avium+ cells. Further HP 
evaluation is necessary to determine if these iNOS- M. avium+ cells express CD68 or 
Arg1+ biomarkers. Given that neutrophils are known component of the granuloma 
cellular environment (Kramnik & Beamer 2016), future multiplex experiments could also 
include biomarkers like myeloperoxidase or LY6G to characterize temporospatial 
patterns of neutrophils within the granulomatous inflammation. Future studies 
investigating the progression and heterogeneity of pulmonary lesions could lead to 
insights into predictive indicators for disease progression.  
Sst1 mediated susceptibility and M. avium infection  
While the sst1 gene has been shown to mediate susceptibility in M.tb, Listeria 
monocytogenes, Chlamydia pneumoniae, and Francisella tularensis LVS (Kramnik and 
Beamer 2016), it has not yet been studied with M. avium infection. Although we did not 
observe granulomas with central areas of caseous necrosis, this could have been because 





aerosolized inoculation of C3HeB/FeJ found that pulmonary lesions with small areas of 
necrosis occurred by 50-60 days post infection (Verma et al., 2019). Although the 
B6.Sst1S mice inoculated with low dose aerosol with virulent M. tb (Ederman strain) 
developed granulomas with necrotic centers by 12 wpi (Kramnik & Beamer 2016), since 
M. avium is less virulent than M. tb, we expect a longer time point for M. avium infection 
to develop this pathology. Therefore, we intend to investigate our model further with a 21 
wpi time point. The ability to generate granulomas with caseous necrotic centers in an M. 
avium model of infection could prove instrumental in expanding research into 
mycobacteriosis associated granulomatous inflammation in the absence of a BSL3 
research facility.  
 
Our findings provide evidence that susceptibility to M. avium infection is 
influenced by the sst1 gene locus with more severe phenotypes when compared to B6 
wild-type mice at 16 wpi but not at 12 wpi. This finding was supported by statistically 
significant M. avium+ cellular expression in the non-inoculated lung lobes of B6.Sst1S 
mice. Given that pulmonary lesions in the non-inoculated lung lobes are interpreted to 
represent bacterial dissemination, this finding suggests enhanced susceptibility to 
bacterial dissemination for the B6.Sst1S mice. Within lesions, the ratio of iNOS+ M. 
avium- to iNOS+ M. avium+ cells (infection ratio) was lower in granulomatous lesions of 
both lobes. This interpretation depends on to what degree these cell phenotypes truly do 
not contain M. avium versus if their M. avium levels are below threshold detection. 





M. avium+ cells within granulomatous lesions) in B6.Sst1S mice, these findings suggest 
that lesions within sst1 susceptible hosts contain fewer supporting cells such as T cells 
and M1 macrophages, even while controlling for level of infection. We also found 
preliminary data suggesting that percent iNOS- M. avium+ cells was greater in the non-
inoculated lung lobes of B6.Sst1S compared non-inoculated lung lobes of B6 mice. This 
difference was not observed in inoculated lung lobes, suggesting the cell phenotype may 
also mediate its effects through secondary lesions. Further workup is necessary to 
identify these cells as either showing positivity for Arg1 or CD68, or potentially 
representing neutrophils.  
In contrast to the established finding that M. tb is susceptible to NO derived from 
macrophages, most research has found that M. avium is resistant to NO from 
macrophages (Appleburg 2016). Murine models have shown that iNOS knockout mice 
are resistant to M. avium infection at both early and late infection time points (Appleburg 
2016). In vitro data has also established that M. avium resistance to NO was independent 
of mycobacterial strain used (Lousada, Florido, & Appelberg, 2007). Our results show 
association between histomorphological pathology and iNOS+, M. avium+ cell 
expression. M. avium+ cells were frequently colocalized with iNOS+, and iNOS+ cells 
were found in areas of increased cellular density and early granulomatous-like pulmonary 
lesions. Future research should use Halo™  Area Quantification analysis to determine 
standardized quantitative outputs for colocalization between M. avium and macrophage 





B6.Sst1S mice do not contradict a role for iNOS in mediating immunopathology, 
although we cannot evaluate cell functionality with our modality.  
Unlike in recent work in NHP models (Flynn et al., 2015), we found that iNOS+, 
Arg1+ cells were a small minority in this population. It would be informative to 
determine if other macrophage populations, such Arg1+ macrophages, become more 
prominent in later time points of infection. Further analysis should also evaluate CD68+ 
M. avium+ iNOS- macrophage phenotypes, as the infection ratio for this phenotype was 
slightly elevated within granulomatous lesions of the non-inoculated lung lobe in B6 
mice compared to B6.Sst1S mice. Given iNOS is associated with immunopathology in 
M. avium infection, this macrophage phenotype could be associated with infection 
control.  
Sst1 Susceptibility mechanistic insights 
Previous research has implicated the Sst1 locus in controlling the macrophage 
stress response and mediating macrophage necrosis (Bhattacharya et al., in preparation). 
Recent research has specifically implicated Sst1 mediated susceptibility to a TNF-
induced dysregulated stress response in macrophages and Type 1 Interferon (IFN1) 
super-induction (Bhattacharya, B., Xiao, S, et al. 2019). Future mIHC and IA 
experiments are planned with B6.Sst1S, IFNβ YFP mice, which have YFP as a reporter 
for IFNβ expression. These experiments will facilitate the ability to phenotype and assess 
the temporospatial characteristics of IFN1 producing cells to investigate their role 





The role of iNOS with respect to the sst1 gene locus is under investigation. 
Previous research argued that sst1 mediated its effect through an iNOS independent 
mechanism (Yan et al., 2007). In an in vitro model of BMDM, PCR results showed that 
TNF treatment lead to the upregulation of IFN beta and iNOS in B6.Sst1S BMDM 
compared to B6 (Kramnik, unpublished observations). Moreover, an IFN alpha/beta 
receptor blocking antibody significantly reduced expression of iNOS in B6.Sst1S BMDM 
compared to B6 (Kramnik, unpublished). This finding suggests that IFN induction, which 
is increased in the sst1 phenotype, is upstream of iNOS expression. Our work shows that 
percent of iNOS+ M. avium+ cells is a marker for susceptibility in B6.Sst1S mice. We 
also found that the infection ratio of iNOS+ M. avium- cells (iNOS+ M. avium- cells in 
lesions/ iNOS+ M. avium+ cells in lesions) was lower in B6.Sst1S lesions. Given that M. 
avium is resistant to NO and is associated with enhanced pathology during M. avium, 
further studies with in vivo and in vitro models are needed to elucidate the functional role 
of iNOS+ M. avium- cells. Since the infection ratio of this macrophage phenotype was 
elevated in lesions of B6 mice, perhaps their function is initially beneficial to resistant 
hosts.  Clarifying the role of iNOS in mycobacterial infection could provide insight into 
whether adjusting iNOS expression is a rational target for HDT.  
Classically, Arg1+ macrophages, or M2 macrophages, are involved with tissue 
repair and induced by the Th2 T cell response (Wynn, 2003). The role of Arg1 is under 
investigation. Since Arg1 competes for iNOS for the common substrate arginine, Arg1 is 
suggested to have immunosuppressive roles in the control of intracellular bacteria such as 





infection (El Kasmi et al., 2008). Arg1+ expression has also been suggested to represent a 
backup effector mechanism (Kramnik & Beamer 2016) given NHP studies finding 
iNOS+ Arg1+ cells in the throughought necrotic granulomas (Mattila et al., 2013), and 
murine M.tb model that found that Arg1 reduced bacterial burden in iNOS knockout 
mice. (Duque-Correa et al., 2014). However, because the macrophage NO effector 
mechanism is not essential for M. avium infection control, the role of Arg1 expression in 
the context of M. avium susceptibility is not well established.  
Previous work with C57BL/6 mice infected with M. avium (10^8) found 
induction of NOS-2 mRNA and a slight increase in Arg1 mRNA expression by 4 wpi 
(Hesse et al., 2001). Our results show enhanced Arg1+ macrophages within, and on, the 
border of relatively larger granulomatous lesions. Arg1+ cells were found within greater 
proximity to double positive M. avium+ iNOS+ cells in B6.Sst1S than B6 at 16 wpi. Our 
finding that larger granulomatous lesions typically expressed Arg1+ cells is consistent 
with the pro-fibrotic function of this phenotype in tissue repair processes (Wynn 2003).  
Additionally, our findings suggest an increased proximity between Arg1+ and 
CD3+ cells, and enhanced Arg1+ cell/CD3+ cell ratio, within granulomatous lesions of 
B6.Sst1S mice compared to B6. We calculated Arg1+ cell/ CD3+ cell ratios to indirectly 
evaluate for a Th2 immune response, given that Il-4 and IL-13 upregulate Arg1 in a 
paracrine fashion (Wynn 2003). These findings suggest that Arg1+ expression within 
lesions could serve as a correlate to susceptibility. Future HP analysis will evaluate 
correlations between granulomatous lesions size and Arg1+ cell expression. Moreover, 





within lesions to gain insight into rate of macrophage polarization, as has recently been 
done in pulmonary tissue samples from patients surgically treated with antibiotic 
sensitive and resistant TB. This study found that antibiotic resistant TB was associated 
with greater M2 polarization (Cho et al., 2020). Given that B6.Sst1S mice may replicate 
caseous necrosis at later M. avium infection timepoints, future mIHC IA studies 
evaluating M2 polarization and Th2 immune could have translationally relevant 
implications to devising effective targets for HDT.  
A barrier to vaccine development against mycobacterium species has been 
identifying patterns of host innate immunity that mediate the underlying 
immunopathology to prevent effective CMI (Yan et al., 2007). Previous work in the 
B6.Sst1S strain argues that the barrier to T cell mediated immunity is that vaccination 
does not alleviate the intrinsic pathway driving macrophage necrosis within granulomas. 
Therefore, antigen specific T cells are not effective in preventing necrosis and bacterial 
dissemination through the lung (Yan et al., 2007). We found that CD3+ cell infection 
ratio (CD3+ cell/ iNOS+ M. avium+ cells within granulomatous lesions) was lower in in 
the B6.Sst1S mice. This implies that at 16 wpi, fewer T cells are integrated within areas 
of inflammation in the susceptible hosts when controlling for level of iNOS+ M. avium+ 
cells.  With biomarkers for T cell subsets like CD4, CD8, and FoxP3 for Tregs, additional 
insight would be garnered about how T cell subtypes influence susceptibility to 
mycobacterial infection.   
Given that our findings showed inconsistent conclusions for CD3+ cell proximity 





influenced T cell proximity. On the one hand, we found increased CD3+ T cell proximity 
within 50 µm of iNOS+ M. avium+ cells in the non-inoculated lung lobes of B6.Sst1S 
compared to B6 mice. However, when comparing to B6 mice, we also found that the 
mean distance between nearest CD3+ cell to every unique iNOS+ M. avium+ cell was 
shorter within TC lesions in B6.Sst1S mice, but longer when the entire lung lube was 
analyzed. This could be explained if in B6.Sst1S mice, iNOS+ M. avium+ cells outside 
of TC lesions are farther away than those within lesions.  
Our contradictory findings emphasize the importance of close examination of 
spatial analysis parameters after running analyses. Employing spatial analysis to multiple, 
and relatively diffuse areas of tissue is difficult because aberrant distances are calculated 
between cells in adjacent classified areas. For example, if two areas of TC lesions are 
separated by an area of non-classified area with CD3+ cells, the distance between the 
iNOS+ M. avium+ cell and the nearest CD3+ cell in a TC lesion is calculated, even if a 
CD3+ cell is closer to the iNOS+ M. avium+ just not in within the classified region. On 
the other hand, whole lung lobe spatial analysis leads to inclusion of cells potentially 
irrelevant to granulomatous formation, such as CD3+ cells within BALT, or Arg1+ cells 
around bronchioles. Future studies should aim to employ spatial analysis parameters to a 
discrete number of granulomatous lesions. Given that the 21 wpi specimens contain 
targeted lesions as identified on MRI, spatial analysis parameters could be designed for 





Limitations and Potential role of mIHC and IA in Infectious Disease Research 
A significant limitation in our methodology was that IHC detection of 
mycobacteria detects both viable and unviable bacterial antigens. This is in contrast to 
chemical stains, such as auramine and rhodamine, which offer the potential to visualize 
distinct mycobacterial bacilli, and clearly characterize intracellular and extracellular 
bacteria. Future experiments could include integration of chemical stains into the 
multiplex to detect these individual bacilli. We also found that having a histopathological 
correlate for mIHC data was helpful to remove outliers. 
 For example, from the histopathology, we were able to determine which 
specimens were also contained eosinophilic crystalline pneumonia, a common secondary 
disease in B6 strain mice. These mice were excluded from analysis as they displayed 
enhanced levels of Arg1 and low levels of M. avium expression. The importance of 
having a trained pathologist evaluate slides is also important when annotating 
components of the lung. There is a great deal of uncertainty in our assumption that the 
non-inoculated lung lobes contain mostly secondary lesions. In fact, we observed likely 
primary lesions around bronchioles in the non-inoculated lung lobes. Future studies with 
IA could consider additional levels of annotations into separate histological pulmonary 
compartments. Finally, we also had a very small sample size for this experiment, so the 
statistical power of our conclusions is small.  
To investigate the role of mycobacterial susceptibility, future studies will continue 
to investigate the role of BMDM in tissue necrosis and its impact CMI in mycobacterial 





quantitative results on the immunopathology of animal tissue. While research into 
immuno-oncology has utilized multiplexed imaging and IA, ID research has yet to fully 
adopt this technology. Recent work employed mIHC and multiplex in situ hybridization 
with IA to analyze changes in biomarkers associated with Ebola virus disease. This study 
found that IA platforms afforded detection of subtle immune and pathological changes 
undetected through standard histopathological approaches (Greenburg et al, in 
preparation). Our implementation of mIHC and IA to study granulomatous inflammation 
in a mouse model of M. avium infection contributes to the growing research field 




















Supplemental Figure 1: Highplex Quantitative image analysis between inoculated 
and non-inoculated lung lobes of an experimental model of M. avium infection in B6 
mice at 12 wpi. (A)-(D) Slightly increased percentages of M. avium+, iNOS+, Arg1+, 
and CD3+ cells in the inoculated lung lobes of B6 mice compared to non-inoculated 
lung lobes, (E) No difference in percent CD68+ in lung lobes of B6 mice.  All cells 
were segmented by DAPI+ nuclei. Biomarker expression determined by fluorophore 
staining in cytoplasm. Quantitative output of % cell type determined by “x”+ cell 
type/ all DAPI+ cells in given lung lobe.  Unpaired t tests, with alpha=0.05.  
 80 
Supplemental Figure 2: Highplex Quantitative image analysis between inoculated 
and non-inoculated lung lobes of an experimental model of M. avium infection in 
B6.Sst1S mice at 12 wpi. (A) Slightly increased percent M. avium+ cells within 
inoculated lung lobe compared to non-inoculated lung lobe in B6.Sst1S mice, (B) no 
difference or slight increase in percent iNOS+ cells in lung lobes of B6.Sst1S, (C) no 
difference or slightly increased percent CD3+ cells in the inoculated lung lobes 
compared to non-inoculated, (D) no difference slightly increased percent Arg1+ cells 
in the non-inoculated lung lobe, (E) no difference in percent CD68+ cells in 
inoculated and non-inoculated lung lobe. All cells were segmented by DAPI+ nuclei. 
Biomarker expression determined by fluorophore staining in cytoplasm. 
Quantitative output of % cell type determined by “x”+ cell type/ all DAPI+ cells in 







Supplemental Figure 3: Highplex Quantitative image analysis of macrophage 
phenotypes within Halo Tissue Classifier recognized granulomatous lesions in the 
inoculated and non-inoculated lung lobes of an experimental model of M. avium 
infection in B6 and B6.Sst1S mice at 16 wpi. (A) Macrophage phenotypes between 
granulomatous lesions of the inoculated and non-inoculated lung lobes of B6 mice 
showed no difference in infection ratio, (B) Macrophage phenotypes between 
granulomatous lesions of the inoculated and non-inoculated lung lobes of B6.Sst1S 
mice showed no difference in infection ratio. All cells were segmented by DAPI+ 
nuclei. Infection ratio was determined by “x”+ cell type/ iNOS+, M. avium+ cells 
within area of classified granulomatous lesions. Biomarker expression determined 
by fluorophore staining in cytoplasm. Quantitative output of % cell type determined 
by “x”+ cell type/ all DAPI+ cells in granulomatous lesions of the given lung lobe. 
Comparison Statistical significance determined without correction for multiple 
comparisons, with alpha=0.05. Each marker on the x-axis was analyzed 






Supplemental Figure 4 Highplex Quantitative image analysis between inoculated 
lung lobes of an experimental model of M. avium infection in B6 and B6.Sst1S mice 
at 12 wpi. (A) Slightly increased percent M. avium+ cells B6 inoculated lobes, (B) no 
difference in percent iNOS+ in inoculated lobes between strains, (C) No difference 
in percent CD3+ cells in the inoculated lung between strains (D)  Increased percent 
arg1+ cells in the inoculated lung lobes of B6.Sst1S mice, (E) no difference in 
percent CD68+ cells in inoculated lung lobes between strains. All cells were 
segmented by DAPI+ nuclei. Biomarker expression determined by fluorophore 
staining in cytoplasm. Quantitative output of % cell type determined by “x”+ cell 









Supplemental Figure 5: Highplex Quantitative image analysis between non-
inoculated lung lobes of an experimental model of M. avium infection in B6 and 
B6.Sst1S mice at 12 wpi. (A) Slightly increased percent M. avium+ cells B6 non-
inoculated lobes, (B) no difference in percent iNOS+ in non-inoculated lobes 
between strains, (C) No difference in percent CD3+ cells in the non-inoculated lung 
between strains (D)  Increased percent arg1+ cells in the non-inoculated lung lobes 
of B6.Sst1S mice, (E) no difference in percent CD68+ cells in non-inoculated lobes 
between strains. All cells were segmented by DAPI+ nuclei. Biomarker expression 
determined by fluorophore staining in cytoplasm. Quantitative output of % cell type 
determined by “x”+ cell type/ all DAPI+ cells in given lung lobe.  Unpaired t tests, 








Supplemental figure 6 : Highplex Quantitative image analysis of macrophage 
phenotypes within Halo Tissue Classifier recognized granulomatous lesions in the 
non-inoculated lung lobes of B6 and B6.Sst1S mice in an experimental model of M. 
avium infection. (A) percentage of macrophage phenotypes with granulomatous 
lesions in non-inoculated lung lobes of B6 mice: 30% iNOS+, M.avium+; 25% 
iNOS+ M. avium-; 2% CD68+, M. avium+, iNOS-, 1% Arg1+, iNOS+, 0.3% Arg1+, 
M.avium+, iNOS-; 0.6% Arg1+, M. avium+, iNOS-, (B) ) percentage of macrophage 
phenotypes with granulomatous lesions  in non-inoculated lung lobes of B6.Sst1S 
mice: 35% iNOS+, M.avium+; 12% iNOS+ M. avium-; 1% CD68+, M. avium+, 
iNOS-, 0.6% Arg1+, iNOS+, 0.5% Arg1+, M.avium+, iNOS-; 0.3% Arg1+, M. 
avium+, iNOS-. All cells were segmented by DAPI+ nuclei. Macrophage phenotype 
expression determined by fluorophore staining in cytoplasm. Quantitative output of 
% cell type determined by “x”+ cell type/ all DAPI+ cells in granulomatous lesions 









Supplemental Figure 7: Highplex Quantitative image analysis of macrophage 
phenotypes within Halo Tissue Classifier recognized granulomatous lesions in B6 
and B6.Sst1S mice in an experimental model of M. avium infection. (A) Macrophage 
phenotypes within granulomatous lesions of the inoculated lung lobes of B6 and 
B6.Sst1S show no difference in infection ratio, (B) ) Macrophage phenotypes within 
granulomatous lesions of the non-inoculated lung lobes of B6 and B6.Sst1S show no 
difference in infection ratio. All cells were segmented by DAPI+ nuclei. Infection 
ratio was determined by “x”+ cell type/ iNOS+, M. avium+ cells within area of 
classified granulomatous lesions. Biomarker expression determined by fluorophore 





type/ all DAPI+ cells in granulomatous lesions of the given lung lobe. Comparison 
Statistical significance determined without correction for multiple comparisons, 
with alpha=0.05. Each marker on the x-axis was analyzed individually, without 
assuming a consistent SD. Number of t tests: 6. 
 
Supplemental Figure 8: Proximity Analysis quantitative spatial image analysis of 
Arg1+ cells within 50 μm of  iNOS+ M. avium+ cells in inoculated and non-
inoculated lung lobes in an experimental model of M. avium infection using B6 and 
B6.Sst1S mice at 12 wpi. (A) No difference in percentage of Arg1+ cells within 50 
μm of iNOS+ M. avium+ cell in the inoculated lung lobes of B6.Sst1S and B6 mice at 
16, (B) No difference in percent Arg1+ cells within 50 μm of iNOS+ M. avium+ cell 
in the non-inoculated lung lobes of B6.Sst1S comparted to B6 mice. Y-axis was 
calculated by taking percent of Arg1+ cells within 50µms of iNOS, M. avium+ cells / 
all Arg1+ cells in given lung lobe. Highplex data was generated by cell segmenting 
cells through DAPI+ nuclei inoculated and non-inoculated lung lobes. Spatial plots 
of each biomarker/phenotype were generated and each cell was given an x,y 
coordinate to facilitate Proximity Analysis Spatial Analysis. Statistical significance 
determined with unpaired t test, with alpha=0.05.  B6.Sst1S contained 3 specimens 






Supplemental Figure 9: Proximity Analysis quantitative spatial image analysis of 
CD3+ cells within 50 μm of  iNOS+ M. avium+ cells in inoculated and non-
inoculated lung lobes in an experimental model of M. avium infection using B6 and 
B6.Sst1S mice at 12 wpi. (A) No difference in percentage of  CD3+ cells within 50 
μm of iNOS+ M. avium+ cell in the inoculated lung lobes of B6.Sst1S and B6 mice at 
16, (B) No difference in percent CD3+ cells within 50 μm of iNOS+ M. avium+ cell in 
the non-inoculated lung lobes of B6.Sst1S comparted to B6 mice. Y-axis was 
calculated by taking percent of CD3+ cells within 50µms of iNOS, M. avium+ cells / 
all CD3++ cells in given lung lobe. Highplex data was generated by cell segmenting 
cells through DAPI+ nuclei inoculated and non-inoculated lung lobes. Spatial plots 
of each biomarker/phenotype were generated and each cell was given an x,y 
coordinate to facilitate Proximity Analysis Spatial Analysis. Statistical significance 
determined with unpaired t test, with alpha=0.05.  B6.Sst1S contained 3 specimens 
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